This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 82 arm-level events and 14 clinical features across 881 patients, 413 significant findings detected with Q value < 0.25.
-
1p gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
1q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
2p gain cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.
-
2q gain cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.
-
3p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
3q gain cnv correlated to 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
4p gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
4q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
5p gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
5q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
6p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
6q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
7p gain cnv correlated to 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
7q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
8p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
8q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
9p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
9q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
10p gain cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.
-
10q gain cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.
-
11p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'NUMBER_PACK_YEARS_SMOKED'.
-
11q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
12p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
12q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
13q gain cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.
-
14q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
15q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
16p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
16q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
17p gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
17q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
18p gain cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
18q gain cnv correlated to 'Time to Death', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
19p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
19q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
20p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
20q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
21q gain cnv correlated to 'KARNOFSKY_PERFORMANCE_SCORE' and 'RACE'.
-
22q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
xp gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
xq gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
1p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
1q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
2p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
2q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
3p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
3q loss cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
4p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
4q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
5p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'ETHNICITY'.
-
5q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'ETHNICITY'.
-
6p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
6q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
7p loss cnv correlated to 'Time to Death' and 'PATHOLOGY_N_STAGE'.
-
7q loss cnv correlated to 'Time to Death' and 'PATHOLOGY_N_STAGE'.
-
8p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
9p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
9q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
10p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
10q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
11p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
11q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
12p loss cnv correlated to 'PATHOLOGY_N_STAGE'.
-
12q loss cnv correlated to 'PATHOLOGY_T_STAGE'.
-
13q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
14q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
15q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
16p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
16q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
17p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
17q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
18p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
18q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'RACE'.
-
19p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
19q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
20p loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
20q loss cnv correlated to 'HISTOLOGICAL_TYPE' and 'ETHNICITY'.
-
21q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
22q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
xp loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
xq loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
PATHOLOGIC STAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
RADIATION THERAPY |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
NUMBER PACK YEARS SMOKED |
YEAR OF TOBACCO SMOKING ONSET |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Wilcoxon-test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | |
12q gain | 256 (29%) | 625 |
0.0636 (0.19) |
0.238 (0.474) |
0.035 (0.124) |
0.0691 (0.203) |
0.00551 (0.0271) |
0.0131 (0.0555) |
0.00573 (0.0279) |
1 (1.00) |
0.0646 (0.191) |
3e-05 (0.000292) |
0.992 (1.00) |
0.309 (0.55) |
0.84 (1.00) |
0.0556 (0.172) |
17p gain | 197 (22%) | 684 |
0.0234 (0.0902) |
0.629 (0.855) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.0156 (0.0636) |
0.0101 (0.0442) |
0.000422 (0.00316) |
1 (1.00) |
0.788 (0.987) |
1e-05 (0.000109) |
0.781 (0.981) |
0.0967 (0.262) |
0.00721 (0.0334) |
0.0103 (0.0447) |
5p loss | 24 (3%) | 857 |
0.052 (0.163) |
0.00256 (0.0143) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.0248 (0.0943) |
0.146 (0.346) |
0.045 (0.146) |
1 (1.00) |
0.103 (0.276) |
1e-05 (0.000109) |
0.0793 (0.224) |
0.333 (0.573) |
0.354 (0.593) |
0.0863 (0.242) |
9p loss | 192 (22%) | 689 |
2.75e-12 (1.58e-09) |
0.079 (0.224) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00502 (0.0254) |
0.000356 (0.00274) |
0.261 (0.504) |
0.373 (0.605) |
0.00208 (0.012) |
1e-05 (0.000109) |
0.796 (0.992) |
0.893 (1.00) |
0.0134 (0.0564) |
0.561 (0.795) |
9q loss | 194 (22%) | 687 |
3.54e-10 (1.02e-07) |
0.0734 (0.211) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.0146 (0.0601) |
0.00107 (0.0069) |
0.227 (0.456) |
0.368 (0.602) |
0.00132 (0.00817) |
1e-05 (0.000109) |
0.974 (1.00) |
0.719 (0.927) |
0.0113 (0.0484) |
1 (1.00) |
14q loss | 265 (30%) | 616 |
1.38e-09 (3.17e-07) |
0.278 (0.522) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00926 (0.0414) |
4.21e-05 (0.000396) |
0.815 (1.00) |
0.0972 (0.263) |
0.000225 (0.00182) |
1e-05 (0.000109) |
0.264 (0.508) |
0.00516 (0.0259) |
0.0227 (0.0879) |
0.864 (1.00) |
22q loss | 107 (12%) | 774 |
0.000828 (0.00559) |
0.641 (0.862) |
1e-05 (0.000109) |
0.00021 (0.00172) |
2e-05 (0.000207) |
0.0271 (0.1) |
0.028 (0.103) |
1 (1.00) |
0.00515 (0.0259) |
1e-05 (0.000109) |
0.899 (1.00) |
0.325 (0.57) |
0.556 (0.79) |
0.0283 (0.104) |
17q gain | 222 (25%) | 659 |
0.171 (0.38) |
0.326 (0.571) |
2e-05 (0.000207) |
5e-05 (0.000452) |
0.00153 (0.00924) |
0.045 (0.146) |
0.0106 (0.0457) |
1 (1.00) |
0.562 (0.795) |
1e-05 (0.000109) |
0.697 (0.909) |
0.128 (0.319) |
0.0097 (0.0428) |
0.034 (0.122) |
1q gain | 68 (8%) | 813 |
2.09e-05 (0.000214) |
0.0431 (0.143) |
0.00023 (0.00185) |
0.00058 (0.00416) |
0.0561 (0.173) |
0.232 (0.465) |
0.505 (0.739) |
1 (1.00) |
0.0515 (0.162) |
0.00326 (0.0175) |
0.282 (0.527) |
0.103 (0.275) |
0.36 (0.6) |
1 (1.00) |
12p gain | 252 (29%) | 629 |
0.0919 (0.253) |
0.128 (0.319) |
0.0612 (0.185) |
0.139 (0.336) |
0.0122 (0.0517) |
0.00883 (0.0396) |
0.00558 (0.0274) |
1 (1.00) |
0.0646 (0.191) |
2e-05 (0.000207) |
0.797 (0.992) |
0.153 (0.355) |
0.961 (1.00) |
0.0568 (0.173) |
2p loss | 65 (7%) | 816 |
0.00434 (0.0226) |
4.59e-05 (0.000428) |
1e-05 (0.000109) |
2e-05 (0.000207) |
0.186 (0.397) |
0.0701 (0.205) |
0.17 (0.379) |
1 (1.00) |
0.0463 (0.149) |
1e-05 (0.000109) |
0.611 (0.844) |
0.96 (1.00) |
0.178 (0.388) |
0.492 (0.723) |
2q loss | 63 (7%) | 818 |
0.00302 (0.0167) |
2.61e-05 (0.000265) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.184 (0.395) |
0.07 (0.205) |
0.166 (0.373) |
1 (1.00) |
0.0463 (0.149) |
1e-05 (0.000109) |
0.331 (0.573) |
0.96 (1.00) |
0.125 (0.315) |
0.492 (0.723) |
3p loss | 412 (47%) | 469 |
0.00243 (0.0138) |
0.898 (1.00) |
0.00045 (0.00329) |
4e-05 (0.00038) |
0.0506 (0.16) |
0.817 (1.00) |
0.72 (0.927) |
0.222 (0.449) |
0.175 (0.384) |
1e-05 (0.000109) |
0.333 (0.573) |
0.0264 (0.098) |
0.00068 (0.00482) |
0.522 (0.757) |
4p loss | 98 (11%) | 783 |
5.05e-12 (1.93e-09) |
0.381 (0.615) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00195 (0.0114) |
0.0146 (0.0601) |
0.068 (0.201) |
1 (1.00) |
0.165 (0.373) |
0.00185 (0.0108) |
0.976 (1.00) |
0.223 (0.451) |
0.113 (0.294) |
0.447 (0.68) |
4q loss | 92 (10%) | 789 |
9.44e-14 (1.08e-10) |
0.478 (0.712) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00138 (0.00843) |
0.000616 (0.00439) |
0.415 (0.65) |
1 (1.00) |
0.144 (0.343) |
0.00847 (0.0383) |
0.886 (1.00) |
0.162 (0.369) |
0.0785 (0.223) |
0.602 (0.836) |
5q loss | 22 (2%) | 859 |
0.361 (0.6) |
0.000184 (0.00155) |
3e-05 (0.000292) |
3e-05 (0.000292) |
0.0495 (0.159) |
0.702 (0.91) |
0.108 (0.285) |
1 (1.00) |
0.795 (0.992) |
1e-05 (0.000109) |
0.037 (0.13) |
0.128 (0.319) |
0.439 (0.675) |
0.0631 (0.19) |
11q loss | 52 (6%) | 829 |
0.000416 (0.00316) |
0.0146 (0.0601) |
9e-05 (0.000783) |
4e-05 (0.00038) |
5e-05 (0.000452) |
0.314 (0.556) |
0.547 (0.784) |
1 (1.00) |
0.0459 (0.149) |
0.0316 (0.115) |
0.536 (0.773) |
0.242 (0.48) |
0.347 (0.586) |
0.503 (0.737) |
13q loss | 137 (16%) | 744 |
0.0366 (0.129) |
0.000117 (0.001) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.0164 (0.0658) |
0.116 (0.298) |
0.0175 (0.07) |
1 (1.00) |
0.664 (0.88) |
1e-05 (0.000109) |
0.933 (1.00) |
0.6 (0.835) |
0.135 (0.33) |
0.641 (0.862) |
15q loss | 69 (8%) | 812 |
2.86e-05 (0.000288) |
0.372 (0.604) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00097 (0.00636) |
0.0139 (0.0579) |
0.506 (0.739) |
1 (1.00) |
0.0791 (0.224) |
0.046 (0.149) |
0.354 (0.593) |
0.291 (0.538) |
0.354 (0.593) |
|
18p loss | 142 (16%) | 739 |
3.28e-07 (5.03e-05) |
0.676 (0.888) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00689 (0.0323) |
0.0256 (0.0963) |
0.698 (0.909) |
1 (1.00) |
0.29 (0.538) |
0.342 (0.582) |
0.176 (0.386) |
0.073 (0.211) |
0.0867 (0.242) |
0.181 (0.39) |
5p gain | 237 (27%) | 644 |
0.418 (0.652) |
0.000456 (0.00331) |
0.00045 (0.00329) |
0.00071 (0.00494) |
0.874 (1.00) |
0.18 (0.389) |
0.044 (0.145) |
0.467 (0.7) |
0.183 (0.393) |
1e-05 (0.000109) |
0.932 (1.00) |
0.644 (0.864) |
0.00021 (0.00172) |
0.857 (1.00) |
5q gain | 248 (28%) | 633 |
0.48 (0.714) |
0.000929 (0.00613) |
0.00155 (0.00927) |
0.00955 (0.0423) |
0.746 (0.951) |
0.151 (0.353) |
0.0802 (0.226) |
0.5 (0.734) |
0.143 (0.343) |
1e-05 (0.000109) |
0.985 (1.00) |
0.747 (0.951) |
0.00043 (0.00321) |
1 (1.00) |
8q gain | 99 (11%) | 782 |
0.0295 (0.108) |
0.19 (0.402) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.0037 (0.0196) |
0.0439 (0.145) |
0.91 (1.00) |
1 (1.00) |
0.322 (0.567) |
0.00147 (0.00893) |
0.359 (0.599) |
0.253 (0.495) |
0.288 (0.535) |
1 (1.00) |
11q gain | 55 (6%) | 826 |
0.247 (0.488) |
0.0536 (0.167) |
0.0357 (0.126) |
0.0093 (0.0414) |
0.604 (0.836) |
0.159 (0.363) |
0.3 (0.546) |
0.22 (0.448) |
0.144 (0.343) |
1e-05 (0.000109) |
0.0422 (0.142) |
0.0498 (0.159) |
0.336 (0.576) |
0.31 (0.55) |
20p gain | 232 (26%) | 649 |
0.372 (0.604) |
0.473 (0.706) |
0.00664 (0.0315) |
0.00326 (0.0175) |
0.072 (0.209) |
0.0344 (0.123) |
0.00115 (0.00736) |
0.2 (0.419) |
0.805 (0.998) |
0.0003 (0.00234) |
0.206 (0.428) |
0.67 (0.885) |
0.288 (0.535) |
0.364 (0.601) |
20q gain | 236 (27%) | 645 |
0.237 (0.472) |
0.28 (0.523) |
0.0052 (0.0259) |
0.00595 (0.0288) |
0.026 (0.0971) |
0.0645 (0.191) |
0.00357 (0.019) |
0.2 (0.419) |
0.805 (0.998) |
0.0002 (0.00168) |
0.269 (0.513) |
0.764 (0.967) |
0.177 (0.386) |
0.285 (0.53) |
xp gain | 124 (14%) | 757 |
0.11 (0.287) |
0.165 (0.373) |
0.0194 (0.0766) |
0.0377 (0.13) |
1 (1.00) |
0.323 (0.567) |
0.0073 (0.0337) |
1 (1.00) |
0.202 (0.421) |
1e-05 (0.000109) |
0.487 (0.72) |
0.0502 (0.16) |
0.0295 (0.108) |
0.661 (0.877) |
8p loss | 164 (19%) | 717 |
0.0151 (0.0619) |
0.822 (1.00) |
0.0236 (0.0904) |
0.0158 (0.064) |
0.577 (0.814) |
0.0572 (0.174) |
0.582 (0.818) |
1 (1.00) |
0.79 (0.988) |
1e-05 (0.000109) |
0.957 (1.00) |
0.666 (0.882) |
0.00498 (0.0254) |
0.143 (0.343) |
11p loss | 43 (5%) | 838 |
0.00492 (0.0253) |
0.0337 (0.121) |
0.00129 (0.00805) |
0.00078 (0.00533) |
0.00107 (0.0069) |
0.393 (0.627) |
0.868 (1.00) |
1 (1.00) |
0.385 (0.618) |
0.0161 (0.0649) |
0.642 (0.862) |
0.125 (0.315) |
0.841 (1.00) |
0.249 (0.489) |
17q loss | 81 (9%) | 800 |
0.00754 (0.0346) |
0.000261 (0.00207) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.179 (0.389) |
0.554 (0.788) |
0.458 (0.691) |
1 (1.00) |
0.00699 (0.0325) |
1e-05 (0.000109) |
0.331 (0.573) |
0.96 (1.00) |
0.128 (0.319) |
0.514 (0.748) |
18q loss | 149 (17%) | 732 |
5.88e-07 (6.32e-05) |
0.601 (0.835) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00155 (0.00927) |
0.0388 (0.133) |
0.924 (1.00) |
1 (1.00) |
0.362 (0.6) |
0.636 (0.861) |
0.304 (0.55) |
0.152 (0.353) |
0.0422 (0.142) |
0.129 (0.319) |
21q loss | 133 (15%) | 748 |
0.908 (1.00) |
0.0566 (0.173) |
0.0008 (0.00543) |
1e-05 (0.000109) |
0.00319 (0.0174) |
1 (1.00) |
0.426 (0.66) |
1 (1.00) |
0.195 (0.413) |
1e-05 (0.000109) |
0.447 (0.68) |
0.0566 (0.173) |
0.104 (0.277) |
0.495 (0.728) |
1p gain | 30 (3%) | 851 |
5.98e-08 (1.14e-05) |
0.216 (0.442) |
0.00299 (0.0166) |
0.00377 (0.0197) |
0.0298 (0.108) |
0.118 (0.302) |
0.24 (0.476) |
1 (1.00) |
0.0252 (0.0952) |
0.366 (0.601) |
0.367 (0.601) |
0.389 (0.623) |
||
7q gain | 370 (42%) | 511 |
0.978 (1.00) |
0.208 (0.43) |
0.0562 (0.173) |
0.95 (1.00) |
0.306 (0.55) |
0.00312 (0.0172) |
1.1e-06 (0.000105) |
0.0959 (0.261) |
0.507 (0.739) |
1e-05 (0.000109) |
0.408 (0.644) |
0.00638 (0.0305) |
0.122 (0.311) |
0.421 (0.655) |
9p gain | 26 (3%) | 855 |
0.159 (0.363) |
0.672 (0.886) |
0.00375 (0.0197) |
0.00521 (0.0259) |
0.0426 (0.142) |
0.344 (0.583) |
0.0102 (0.0446) |
1 (1.00) |
0.0907 (0.251) |
5e-05 (0.000452) |
0.298 (0.546) |
0.38 (0.615) |
0.389 (0.623) |
|
9q gain | 24 (3%) | 857 |
0.47 (0.704) |
0.675 (0.888) |
0.00131 (0.00813) |
9e-05 (0.000783) |
0.0425 (0.142) |
1 (1.00) |
0.045 (0.146) |
1 (1.00) |
0.0907 (0.251) |
2e-05 (0.000207) |
0.298 (0.546) |
0.218 (0.444) |
0.366 (0.601) |
|
11p gain | 57 (6%) | 824 |
0.728 (0.936) |
0.125 (0.315) |
0.00652 (0.0311) |
0.00255 (0.0143) |
0.299 (0.546) |
0.0373 (0.13) |
0.562 (0.795) |
0.208 (0.43) |
0.35 (0.589) |
1e-05 (0.000109) |
0.0636 (0.19) |
0.152 (0.353) |
0.25 (0.491) |
0.33 (0.573) |
14q gain | 39 (4%) | 842 |
0.819 (1.00) |
0.0435 (0.144) |
0.00178 (0.0105) |
0.00045 (0.00329) |
0.463 (0.696) |
0.585 (0.82) |
0.489 (0.721) |
1 (1.00) |
0.223 (0.451) |
1e-05 (0.000109) |
0.1 (0.27) |
0.084 (0.236) |
0.267 (0.511) |
0.668 (0.884) |
16p gain | 281 (32%) | 600 |
0.0206 (0.081) |
0.0117 (0.05) |
0.816 (1.00) |
0.876 (1.00) |
0.216 (0.442) |
0.896 (1.00) |
0.00211 (0.0122) |
0.562 (0.795) |
0.866 (1.00) |
1e-05 (0.000109) |
0.979 (1.00) |
0.309 (0.55) |
0.0368 (0.129) |
0.613 (0.846) |
19p gain | 75 (9%) | 806 |
0.651 (0.869) |
0.735 (0.941) |
1e-05 (0.000109) |
2e-05 (0.000207) |
0.153 (0.355) |
0.00372 (0.0196) |
0.522 (0.757) |
0.214 (0.439) |
0.991 (1.00) |
1e-05 (0.000109) |
0.407 (0.644) |
0.126 (0.315) |
0.00103 (0.00672) |
1 (1.00) |
19q gain | 78 (9%) | 803 |
0.514 (0.748) |
0.817 (1.00) |
1e-05 (0.000109) |
6e-05 (0.00053) |
0.625 (0.852) |
0.00117 (0.00745) |
0.53 (0.765) |
0.201 (0.421) |
0.991 (1.00) |
1e-05 (0.000109) |
0.731 (0.939) |
0.202 (0.421) |
0.00086 (0.00577) |
1 (1.00) |
xq gain | 125 (14%) | 756 |
0.136 (0.331) |
0.218 (0.444) |
0.0203 (0.0799) |
0.0744 (0.213) |
0.907 (1.00) |
0.162 (0.369) |
0.0104 (0.0449) |
1 (1.00) |
0.143 (0.343) |
1e-05 (0.000109) |
0.6 (0.835) |
0.152 (0.353) |
0.0352 (0.125) |
0.661 (0.877) |
1q loss | 110 (12%) | 771 |
0.0388 (0.133) |
0.000693 (0.00488) |
1e-05 (0.000109) |
5e-05 (0.000452) |
0.199 (0.419) |
0.114 (0.295) |
0.331 (0.573) |
1 (1.00) |
0.3 (0.546) |
1e-05 (0.000109) |
0.445 (0.68) |
0.96 (1.00) |
0.0923 (0.254) |
0.309 (0.55) |
3q loss | 124 (14%) | 757 |
0.173 (0.382) |
0.0446 (0.146) |
0.146 (0.346) |
0.221 (0.449) |
0.277 (0.521) |
0.451 (0.684) |
0.0397 (0.135) |
0.0164 (0.0658) |
0.367 (0.601) |
1e-05 (0.000109) |
0.0395 (0.134) |
0.632 (0.858) |
||
6p loss | 172 (20%) | 709 |
0.78 (0.981) |
0.0737 (0.211) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.129 (0.319) |
0.89 (1.00) |
0.527 (0.764) |
1 (1.00) |
0.186 (0.397) |
1e-05 (0.000109) |
0.367 (0.601) |
0.701 (0.91) |
0.00025 (0.00199) |
0.672 (0.886) |
6q loss | 206 (23%) | 675 |
0.123 (0.313) |
0.0738 (0.211) |
6e-05 (0.00053) |
3e-05 (0.000292) |
0.133 (0.325) |
0.896 (1.00) |
0.554 (0.788) |
1 (1.00) |
0.298 (0.546) |
1e-05 (0.000109) |
0.142 (0.342) |
0.639 (0.862) |
0.00022 (0.00179) |
0.329 (0.573) |
16p loss | 18 (2%) | 863 |
6.06e-07 (6.32e-05) |
0.974 (1.00) |
0.00851 (0.0383) |
0.00042 (0.00316) |
0.00127 (0.00801) |
0.702 (0.91) |
0.618 (0.847) |
1 (1.00) |
0.0689 (0.203) |
1 (1.00) |
1 (1.00) |
|||
17p loss | 109 (12%) | 772 |
0.548 (0.786) |
0.00319 (0.0174) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.00128 (0.00803) |
0.165 (0.373) |
0.328 (0.572) |
1 (1.00) |
0.206 (0.428) |
1e-05 (0.000109) |
0.86 (1.00) |
0.837 (1.00) |
0.485 (0.719) |
1 (1.00) |
19p loss | 27 (3%) | 854 |
0.00074 (0.00511) |
0.148 (0.348) |
0.00482 (0.0249) |
0.00164 (0.00975) |
0.0377 (0.13) |
0.408 (0.644) |
1 (1.00) |
1 (1.00) |
0.256 (0.497) |
0.0135 (0.0565) |
0.581 (0.818) |
0.875 (1.00) |
1 (1.00) |
|
19q loss | 22 (2%) | 859 |
0.00121 (0.0077) |
0.332 (0.573) |
0.0007 (0.0049) |
4e-05 (0.00038) |
0.00011 (0.000949) |
0.256 (0.497) |
0.819 (1.00) |
1 (1.00) |
0.256 (0.497) |
0.00021 (0.00172) |
0.392 (0.626) |
0.18 (0.389) |
0.313 (0.556) |
1 (1.00) |
xp loss | 118 (13%) | 763 |
0.291 (0.538) |
0.000927 (0.00613) |
0.00051 (0.00368) |
0.00015 (0.00128) |
0.00611 (0.0295) |
1 (1.00) |
0.248 (0.488) |
1 (1.00) |
0.714 (0.923) |
1e-05 (0.000109) |
0.812 (1.00) |
0.452 (0.684) |
0.249 (0.49) |
0.212 (0.437) |
xq loss | 116 (13%) | 765 |
0.3 (0.546) |
0.00135 (0.00829) |
0.00076 (0.00522) |
0.00033 (0.00256) |
0.00566 (0.0276) |
0.603 (0.836) |
0.342 (0.582) |
1 (1.00) |
0.382 (0.615) |
1e-05 (0.000109) |
0.97 (1.00) |
0.841 (1.00) |
0.114 (0.295) |
0.303 (0.549) |
3p gain | 102 (12%) | 779 |
0.888 (1.00) |
0.159 (0.363) |
0.0328 (0.118) |
0.0213 (0.0832) |
0.0258 (0.0966) |
1 (1.00) |
0.146 (0.346) |
1 (1.00) |
0.156 (0.36) |
1e-05 (0.000109) |
0.882 (1.00) |
0.472 (0.706) |
0.338 (0.578) |
0.808 (1.00) |
3q gain | 158 (18%) | 723 |
0.342 (0.582) |
0.138 (0.334) |
0.637 (0.861) |
0.416 (0.651) |
0.0639 (0.19) |
0.247 (0.488) |
0.0249 (0.0944) |
1 (1.00) |
0.657 (0.876) |
1e-05 (0.000109) |
0.861 (1.00) |
0.446 (0.68) |
0.0782 (0.223) |
0.84 (1.00) |
4p gain | 46 (5%) | 835 |
0.583 (0.82) |
0.0388 (0.133) |
0.0034 (0.0182) |
0.00669 (0.0315) |
0.152 (0.353) |
0.585 (0.82) |
0.75 (0.953) |
1 (1.00) |
0.735 (0.941) |
1e-05 (0.000109) |
0.15 (0.353) |
0.323 (0.567) |
0.302 (0.549) |
0.447 (0.68) |
4q gain | 46 (5%) | 835 |
0.255 (0.497) |
0.0425 (0.142) |
0.0114 (0.049) |
0.0211 (0.0827) |
0.133 (0.326) |
0.784 (0.984) |
0.872 (1.00) |
1 (1.00) |
0.778 (0.981) |
1e-05 (0.000109) |
0.305 (0.55) |
0.236 (0.471) |
0.306 (0.55) |
0.438 (0.673) |
6q gain | 16 (2%) | 865 |
0.0127 (0.054) |
0.677 (0.888) |
0.0235 (0.0903) |
0.0516 (0.162) |
0.00842 (0.0382) |
0.154 (0.355) |
0.599 (0.835) |
1 (1.00) |
0.779 (0.981) |
0.318 (0.563) |
0.352 (0.592) |
0.622 (0.849) |
0.47 (0.704) |
1 (1.00) |
7p gain | 368 (42%) | 513 |
0.66 (0.877) |
0.171 (0.379) |
0.199 (0.418) |
0.96 (1.00) |
0.34 (0.58) |
0.0241 (0.0918) |
3.51e-07 (5.03e-05) |
0.594 (0.832) |
0.356 (0.595) |
1e-05 (0.000109) |
0.369 (0.602) |
0.00638 (0.0305) |
0.133 (0.326) |
0.422 (0.655) |
8p gain | 67 (8%) | 814 |
0.376 (0.609) |
0.552 (0.788) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.073 (0.211) |
0.176 (0.385) |
0.789 (0.987) |
1 (1.00) |
0.81 (1.00) |
1e-05 (0.000109) |
0.964 (1.00) |
0.321 (0.567) |
0.309 (0.55) |
1 (1.00) |
15q gain | 52 (6%) | 829 |
0.262 (0.505) |
0.342 (0.582) |
0.00091 (0.00607) |
0.00321 (0.0174) |
0.497 (0.73) |
0.474 (0.707) |
0.649 (0.867) |
1 (1.00) |
0.911 (1.00) |
1e-05 (0.000109) |
0.418 (0.652) |
0.0588 (0.178) |
0.373 (0.605) |
0.269 (0.513) |
16q gain | 268 (30%) | 613 |
0.00224 (0.0129) |
0.0294 (0.108) |
0.39 (0.623) |
0.676 (0.888) |
1 (1.00) |
0.423 (0.656) |
0.0102 (0.0446) |
1 (1.00) |
0.693 (0.907) |
1e-05 (0.000109) |
0.616 (0.846) |
0.309 (0.55) |
0.0908 (0.251) |
0.735 (0.941) |
1p loss | 145 (16%) | 736 |
0.165 (0.373) |
0.0183 (0.073) |
6e-05 (0.00053) |
1e-05 (0.000109) |
0.268 (0.512) |
0.119 (0.305) |
0.564 (0.797) |
1 (1.00) |
0.416 (0.651) |
1e-05 (0.000109) |
0.367 (0.601) |
0.253 (0.495) |
0.641 (0.862) |
0.108 (0.285) |
10p loss | 131 (15%) | 750 |
0.703 (0.91) |
0.0621 (0.188) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.167 (0.376) |
1 (1.00) |
0.616 (0.846) |
1 (1.00) |
0.537 (0.773) |
1e-05 (0.000109) |
0.173 (0.382) |
0.448 (0.68) |
0.382 (0.615) |
0.22 (0.448) |
10q loss | 156 (18%) | 725 |
0.987 (1.00) |
0.035 (0.124) |
1e-05 (0.000109) |
1e-05 (0.000109) |
0.382 (0.615) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.809 (1.00) |
1e-05 (0.000109) |
0.173 (0.382) |
0.448 (0.68) |
0.14 (0.338) |
0.263 (0.505) |
16q loss | 28 (3%) | 853 |
4.99e-07 (6.32e-05) |
0.401 (0.638) |
0.00502 (0.0254) |
0.00027 (0.00212) |
0.00042 (0.00316) |
0.72 (0.927) |
1 (1.00) |
1 (1.00) |
0.168 (0.377) |
0.113 (0.294) |
0.179 (0.389) |
0.867 (1.00) |
0.87 (1.00) |
0.621 (0.849) |
6p gain | 21 (2%) | 860 |
0.131 (0.321) |
0.553 (0.788) |
0.00262 (0.0146) |
0.00493 (0.0253) |
0.00245 (0.0139) |
0.0954 (0.26) |
0.483 (0.717) |
1 (1.00) |
0.779 (0.981) |
0.196 (0.413) |
0.958 (1.00) |
0.792 (0.99) |
0.691 (0.905) |
0.616 (0.846) |
18p gain | 54 (6%) | 827 |
0.0223 (0.0864) |
0.781 (0.981) |
0.44 (0.675) |
0.529 (0.765) |
1 (1.00) |
0.636 (0.861) |
0.552 (0.788) |
1 (1.00) |
0.126 (0.315) |
1e-05 (0.000109) |
0.265 (0.508) |
0.43 (0.663) |
0.0715 (0.208) |
0.3 (0.546) |
18q gain | 50 (6%) | 831 |
0.00698 (0.0325) |
0.798 (0.992) |
0.404 (0.642) |
0.429 (0.663) |
0.453 (0.685) |
0.461 (0.694) |
0.284 (0.529) |
1 (1.00) |
0.0262 (0.0978) |
1e-05 (0.000109) |
0.886 (1.00) |
0.43 (0.663) |
0.104 (0.277) |
0.276 (0.52) |
22q gain | 64 (7%) | 817 |
0.536 (0.773) |
0.364 (0.601) |
0.0153 (0.0625) |
0.00173 (0.0102) |
0.196 (0.413) |
0.834 (1.00) |
0.411 (0.646) |
0.214 (0.439) |
1 (1.00) |
1e-05 (0.000109) |
0.716 (0.925) |
0.413 (0.648) |
0.0951 (0.26) |
0.3 (0.546) |
2p gain | 119 (14%) | 762 |
0.619 (0.848) |
0.271 (0.514) |
0.453 (0.685) |
0.144 (0.343) |
0.0436 (0.144) |
0.869 (1.00) |
1 (1.00) |
0.323 (0.567) |
0.158 (0.362) |
0.0192 (0.0762) |
0.185 (0.395) |
0.849 (1.00) |
0.699 (0.909) |
0.813 (1.00) |
2q gain | 127 (14%) | 754 |
0.679 (0.89) |
0.233 (0.467) |
0.52 (0.756) |
0.272 (0.514) |
0.022 (0.0855) |
0.748 (0.951) |
0.543 (0.78) |
0.351 (0.591) |
0.25 (0.49) |
0.00829 (0.0378) |
0.336 (0.576) |
0.831 (1.00) |
0.703 (0.91) |
0.649 (0.867) |
10p gain | 30 (3%) | 851 |
0.401 (0.638) |
0.635 (0.861) |
0.107 (0.284) |
0.00533 (0.0264) |
0.0403 (0.137) |
1 (1.00) |
0.695 (0.908) |
1 (1.00) |
0.636 (0.861) |
0.419 (0.653) |
0.753 (0.955) |
0.139 (0.336) |
0.625 (0.852) |
|
10q gain | 23 (3%) | 858 |
0.212 (0.437) |
0.26 (0.503) |
0.434 (0.668) |
0.0714 (0.208) |
0.0374 (0.13) |
0.752 (0.955) |
0.369 (0.602) |
1 (1.00) |
1 (1.00) |
0.839 (1.00) |
0.111 (0.29) |
0.616 (0.846) |
||
13q gain | 53 (6%) | 828 |
0.17 (0.379) |
0.277 (0.521) |
0.755 (0.956) |
0.832 (1.00) |
0.409 (0.645) |
0.798 (0.992) |
0.0997 (0.269) |
0.0134 (0.0563) |
0.74 (0.945) |
0.00232 (0.0133) |
1 (1.00) |
0.876 (1.00) |
0.833 (1.00) |
0.182 (0.391) |
21q gain | 73 (8%) | 808 |
0.481 (0.714) |
0.487 (0.72) |
0.349 (0.589) |
0.176 (0.386) |
1 (1.00) |
0.295 (0.543) |
0.606 (0.838) |
1 (1.00) |
0.0394 (0.134) |
0.347 (0.586) |
0.447 (0.68) |
0.627 (0.854) |
0.0534 (0.167) |
0.773 (0.977) |
7p loss | 4 (0%) | 877 |
0.089 (0.247) |
0.407 (0.644) |
0.27 (0.513) |
0.109 (0.287) |
0.0498 (0.159) |
1 (1.00) |
0.308 (0.55) |
1 (1.00) |
0.362 (0.6) |
1 (1.00) |
1 (1.00) |
|||
7q loss | 4 (0%) | 877 |
0.089 (0.247) |
0.407 (0.644) |
0.272 (0.514) |
0.109 (0.287) |
0.0509 (0.161) |
1 (1.00) |
0.308 (0.55) |
1 (1.00) |
0.362 (0.6) |
1 (1.00) |
1 (1.00) |
|||
20q loss | 6 (1%) | 875 |
0.857 (1.00) |
0.124 (0.315) |
0.11 (0.288) |
0.168 (0.377) |
0.0933 (0.256) |
0.598 (0.835) |
1 (1.00) |
1 (1.00) |
0.008 (0.0366) |
0.645 (0.865) |
0.0633 (0.19) |
|||
8q loss | 87 (10%) | 794 |
0.837 (1.00) |
0.328 (0.572) |
0.334 (0.573) |
0.18 (0.389) |
1 (1.00) |
0.601 (0.835) |
0.187 (0.398) |
1 (1.00) |
0.55 (0.788) |
1e-05 (0.000109) |
0.939 (1.00) |
0.152 (0.353) |
0.259 (0.501) |
|
12p loss | 7 (1%) | 874 |
0.129 (0.319) |
0.739 (0.944) |
0.148 (0.348) |
0.107 (0.284) |
0.0506 (0.16) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.1 (0.269) |
1 (1.00) |
1 (1.00) |
|||
12q loss | 4 (0%) | 877 |
0.988 (1.00) |
0.332 (0.573) |
0.27 (0.513) |
0.0549 (0.17) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.174 (0.384) |
1 (1.00) |
1 (1.00) |
||||
20p loss | 12 (1%) | 869 |
0.461 (0.694) |
0.231 (0.464) |
0.12 (0.307) |
0.131 (0.321) |
0.106 (0.282) |
0.658 (0.877) |
0.227 (0.456) |
1 (1.00) |
0.00667 (0.0315) |
0.125 (0.315) |
0.28 (0.523) |
P value = 5.98e-08 (logrank test), Q value = 1.1e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
1P GAIN MUTATED | 29 | 18 | 0.5 - 118.8 (22.3) |
1P GAIN WILD-TYPE | 844 | 210 | 0.1 - 194.8 (35.9) |
P value = 0.00299 (Fisher's exact test), Q value = 0.017
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
1P GAIN MUTATED | 7 | 4 | 12 | 7 |
1P GAIN WILD-TYPE | 448 | 100 | 179 | 97 |
P value = 0.00377 (Fisher's exact test), Q value = 0.02
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
1P GAIN MUTATED | 8 | 4 | 18 | 0 |
1P GAIN WILD-TYPE | 471 | 123 | 240 | 15 |
P value = 0.0298 (Fisher's exact test), Q value = 0.11
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
1P GAIN MUTATED | 11 | 5 | 1 |
1P GAIN WILD-TYPE | 311 | 39 | 6 |
P value = 0.0252 (Wilcoxon-test), Q value = 0.095
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
1P GAIN MUTATED | 6 | 46.7 (51.3) |
1P GAIN WILD-TYPE | 136 | 89.4 (19.2) |
P value = 2.09e-05 (logrank test), Q value = 0.00021
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
1Q GAIN MUTATED | 67 | 31 | 0.4 - 129.4 (25.4) |
1Q GAIN WILD-TYPE | 806 | 197 | 0.1 - 194.8 (36.0) |
P value = 0.0431 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
1Q GAIN MUTATED | 66 | 62.7 (12.1) |
1Q GAIN WILD-TYPE | 809 | 59.9 (12.5) |
P value = 0.00023 (Fisher's exact test), Q value = 0.0018
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
1Q GAIN MUTATED | 20 | 9 | 27 | 12 |
1Q GAIN WILD-TYPE | 435 | 95 | 164 | 92 |
P value = 0.00058 (Fisher's exact test), Q value = 0.0042
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
1Q GAIN MUTATED | 23 | 11 | 34 | 0 |
1Q GAIN WILD-TYPE | 456 | 116 | 224 | 15 |
P value = 0.0561 (Fisher's exact test), Q value = 0.17
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
1Q GAIN MUTATED | 28 | 9 | 1 |
1Q GAIN WILD-TYPE | 294 | 35 | 6 |
P value = 0.0515 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
1Q GAIN MUTATED | 11 | 60.0 (47.7) |
1Q GAIN WILD-TYPE | 131 | 89.9 (17.9) |
P value = 0.00326 (Fisher's exact test), Q value = 0.017
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
1Q GAIN MUTATED | 0 | 51 | 17 |
1Q GAIN WILD-TYPE | 66 | 477 | 270 |
P value = 0.0436 (Fisher's exact test), Q value = 0.14
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
2P GAIN MUTATED | 42 | 11 | 2 |
2P GAIN WILD-TYPE | 280 | 33 | 5 |
P value = 0.0192 (Fisher's exact test), Q value = 0.076
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
2P GAIN MUTATED | 2 | 75 | 42 |
2P GAIN WILD-TYPE | 64 | 453 | 245 |
P value = 0.022 (Fisher's exact test), Q value = 0.085
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
2Q GAIN MUTATED | 45 | 11 | 3 |
2Q GAIN WILD-TYPE | 277 | 33 | 4 |
P value = 0.00829 (Fisher's exact test), Q value = 0.038
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
2Q GAIN MUTATED | 2 | 78 | 47 |
2Q GAIN WILD-TYPE | 64 | 450 | 240 |
P value = 0.0328 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
3P GAIN MUTATED | 58 | 15 | 11 | 11 |
3P GAIN WILD-TYPE | 397 | 89 | 180 | 93 |
P value = 0.0213 (Fisher's exact test), Q value = 0.083
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
3P GAIN MUTATED | 61 | 19 | 18 | 3 |
3P GAIN WILD-TYPE | 418 | 108 | 240 | 12 |
P value = 0.0258 (Fisher's exact test), Q value = 0.097
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
3P GAIN MUTATED | 21 | 8 | 1 |
3P GAIN WILD-TYPE | 301 | 36 | 6 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
3P GAIN MUTATED | 8 | 19 | 75 |
3P GAIN WILD-TYPE | 58 | 509 | 212 |
P value = 0.0639 (Fisher's exact test), Q value = 0.19
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
3Q GAIN MUTATED | 45 | 12 | 1 |
3Q GAIN WILD-TYPE | 277 | 32 | 6 |
P value = 0.0249 (Fisher's exact test), Q value = 0.094
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
3Q GAIN MUTATED | 40 | 118 |
3Q GAIN WILD-TYPE | 252 | 471 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
3Q GAIN MUTATED | 8 | 56 | 94 |
3Q GAIN WILD-TYPE | 58 | 472 | 193 |
P value = 0.0782 (Fisher's exact test), Q value = 0.22
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
3Q GAIN MUTATED | 2 | 2 | 20 | 125 |
3Q GAIN WILD-TYPE | 0 | 13 | 101 | 594 |
P value = 0.0388 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
4P GAIN MUTATED | 45 | 56.5 (13.4) |
4P GAIN WILD-TYPE | 830 | 60.3 (12.4) |
P value = 0.0034 (Fisher's exact test), Q value = 0.018
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
4P GAIN MUTATED | 18 | 13 | 6 | 8 |
4P GAIN WILD-TYPE | 437 | 91 | 185 | 96 |
P value = 0.00669 (Fisher's exact test), Q value = 0.031
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
4P GAIN MUTATED | 18 | 14 | 12 | 2 |
4P GAIN WILD-TYPE | 461 | 113 | 246 | 13 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
4P GAIN MUTATED | 23 | 13 | 10 |
4P GAIN WILD-TYPE | 43 | 515 | 277 |
P value = 0.0425 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
4Q GAIN MUTATED | 45 | 56.6 (13.3) |
4Q GAIN WILD-TYPE | 830 | 60.3 (12.4) |
P value = 0.0114 (Fisher's exact test), Q value = 0.049
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
4Q GAIN MUTATED | 19 | 13 | 7 | 6 |
4Q GAIN WILD-TYPE | 436 | 91 | 184 | 98 |
P value = 0.0211 (Fisher's exact test), Q value = 0.083
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
4Q GAIN MUTATED | 19 | 14 | 12 | 1 |
4Q GAIN WILD-TYPE | 460 | 113 | 246 | 14 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
4Q GAIN MUTATED | 24 | 13 | 9 |
4Q GAIN WILD-TYPE | 42 | 515 | 278 |
P value = 0.000456 (Wilcoxon-test), Q value = 0.0033
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
5P GAIN MUTATED | 235 | 62.7 (12.3) |
5P GAIN WILD-TYPE | 640 | 59.2 (12.5) |
P value = 0.00045 (Fisher's exact test), Q value = 0.0033
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
5P GAIN MUTATED | 101 | 27 | 64 | 42 |
5P GAIN WILD-TYPE | 354 | 77 | 127 | 62 |
P value = 0.00071 (Fisher's exact test), Q value = 0.0049
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
5P GAIN MUTATED | 105 | 35 | 90 | 7 |
5P GAIN WILD-TYPE | 374 | 92 | 168 | 8 |
P value = 0.044 (Fisher's exact test), Q value = 0.14
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
5P GAIN MUTATED | 66 | 171 |
5P GAIN WILD-TYPE | 226 | 418 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
5P GAIN MUTATED | 8 | 195 | 34 |
5P GAIN WILD-TYPE | 58 | 333 | 253 |
P value = 0.00021 (Fisher's exact test), Q value = 0.0017
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
5P GAIN MUTATED | 0 | 4 | 15 | 213 |
5P GAIN WILD-TYPE | 2 | 11 | 106 | 506 |
P value = 0.000929 (Wilcoxon-test), Q value = 0.0061
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
5Q GAIN MUTATED | 245 | 62.5 (12.4) |
5Q GAIN WILD-TYPE | 630 | 59.2 (12.4) |
P value = 0.00155 (Fisher's exact test), Q value = 0.0093
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
5Q GAIN MUTATED | 111 | 27 | 63 | 44 |
5Q GAIN WILD-TYPE | 344 | 77 | 128 | 60 |
P value = 0.00955 (Fisher's exact test), Q value = 0.042
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
5Q GAIN MUTATED | 116 | 35 | 91 | 6 |
5Q GAIN WILD-TYPE | 363 | 92 | 167 | 9 |
P value = 0.0802 (Fisher's exact test), Q value = 0.23
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
5Q GAIN MUTATED | 71 | 177 |
5Q GAIN WILD-TYPE | 221 | 412 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
5Q GAIN MUTATED | 8 | 208 | 32 |
5Q GAIN WILD-TYPE | 58 | 320 | 255 |
P value = 0.00043 (Fisher's exact test), Q value = 0.0032
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
5Q GAIN MUTATED | 0 | 4 | 17 | 222 |
5Q GAIN WILD-TYPE | 2 | 11 | 104 | 497 |
P value = 0.00262 (Fisher's exact test), Q value = 0.015
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
6P GAIN MUTATED | 6 | 0 | 9 | 6 |
6P GAIN WILD-TYPE | 449 | 104 | 182 | 98 |
P value = 0.00493 (Fisher's exact test), Q value = 0.025
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
6P GAIN MUTATED | 6 | 1 | 13 | 1 |
6P GAIN WILD-TYPE | 473 | 126 | 245 | 14 |
P value = 0.00245 (Fisher's exact test), Q value = 0.014
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
6P GAIN MUTATED | 6 | 6 | 0 |
6P GAIN WILD-TYPE | 316 | 38 | 7 |
P value = 0.0127 (logrank test), Q value = 0.054
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
6Q GAIN MUTATED | 16 | 8 | 6.4 - 113.5 (27.7) |
6Q GAIN WILD-TYPE | 857 | 220 | 0.1 - 194.8 (34.9) |
P value = 0.0235 (Fisher's exact test), Q value = 0.09
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
6Q GAIN MUTATED | 5 | 0 | 7 | 4 |
6Q GAIN WILD-TYPE | 450 | 104 | 184 | 100 |
P value = 0.0516 (Fisher's exact test), Q value = 0.16
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
6Q GAIN MUTATED | 5 | 1 | 10 | 0 |
6Q GAIN WILD-TYPE | 474 | 126 | 248 | 15 |
P value = 0.00842 (Fisher's exact test), Q value = 0.038
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
6Q GAIN MUTATED | 5 | 5 | 0 |
6Q GAIN WILD-TYPE | 317 | 39 | 7 |
P value = 0.0241 (Fisher's exact test), Q value = 0.092
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
7P GAIN MUTATED | 192 | 43 |
7P GAIN WILD-TYPE | 353 | 46 |
P value = 3.51e-07 (Fisher's exact test), Q value = 5e-05
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
7P GAIN MUTATED | 87 | 281 |
7P GAIN WILD-TYPE | 205 | 308 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
7P GAIN MUTATED | 24 | 172 | 172 |
7P GAIN WILD-TYPE | 42 | 356 | 115 |
P value = 0.00638 (Wilcoxon-test), Q value = 0.031
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
7P GAIN MUTATED | 38 | 1968.8 (15.1) |
7P GAIN WILD-TYPE | 36 | 1978.9 (15.5) |
P value = 0.0562 (Fisher's exact test), Q value = 0.17
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
7Q GAIN MUTATED | 192 | 38 | 70 | 54 |
7Q GAIN WILD-TYPE | 263 | 66 | 121 | 50 |
P value = 0.00312 (Fisher's exact test), Q value = 0.017
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
7Q GAIN MUTATED | 191 | 46 |
7Q GAIN WILD-TYPE | 354 | 43 |
P value = 1.1e-06 (Fisher's exact test), Q value = 1e-04
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
7Q GAIN MUTATED | 89 | 281 |
7Q GAIN WILD-TYPE | 203 | 308 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
7Q GAIN MUTATED | 24 | 173 | 173 |
7Q GAIN WILD-TYPE | 42 | 355 | 114 |
P value = 0.00638 (Wilcoxon-test), Q value = 0.031
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
7Q GAIN MUTATED | 38 | 1968.8 (15.1) |
7Q GAIN WILD-TYPE | 36 | 1978.9 (15.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
8P GAIN MUTATED | 18 | 19 | 16 | 13 |
8P GAIN WILD-TYPE | 437 | 85 | 175 | 91 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
8P GAIN MUTATED | 18 | 20 | 28 | 1 |
8P GAIN WILD-TYPE | 461 | 107 | 230 | 14 |
P value = 0.073 (Fisher's exact test), Q value = 0.21
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
8P GAIN MUTATED | 29 | 7 | 2 |
8P GAIN WILD-TYPE | 293 | 37 | 5 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
8P GAIN MUTATED | 17 | 30 | 20 |
8P GAIN WILD-TYPE | 49 | 498 | 267 |
P value = 0.0295 (logrank test), Q value = 0.11
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
8Q GAIN MUTATED | 98 | 32 | 0.2 - 152.0 (26.7) |
8Q GAIN WILD-TYPE | 775 | 196 | 0.1 - 194.8 (36.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
8Q GAIN MUTATED | 27 | 22 | 29 | 20 |
8Q GAIN WILD-TYPE | 428 | 82 | 162 | 84 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
8Q GAIN MUTATED | 27 | 23 | 47 | 2 |
8Q GAIN WILD-TYPE | 452 | 104 | 211 | 13 |
P value = 0.0037 (Fisher's exact test), Q value = 0.02
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
8Q GAIN MUTATED | 39 | 12 | 3 |
8Q GAIN WILD-TYPE | 283 | 32 | 4 |
P value = 0.0439 (Fisher's exact test), Q value = 0.14
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
8Q GAIN MUTATED | 55 | 16 |
8Q GAIN WILD-TYPE | 490 | 73 |
P value = 0.00147 (Fisher's exact test), Q value = 0.0089
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
8Q GAIN MUTATED | 17 | 57 | 25 |
8Q GAIN WILD-TYPE | 49 | 471 | 262 |
P value = 0.00375 (Fisher's exact test), Q value = 0.02
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
9P GAIN MUTATED | 7 | 9 | 7 | 3 |
9P GAIN WILD-TYPE | 448 | 95 | 184 | 101 |
P value = 0.00521 (Fisher's exact test), Q value = 0.026
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
9P GAIN MUTATED | 7 | 9 | 9 | 1 |
9P GAIN WILD-TYPE | 472 | 118 | 249 | 14 |
P value = 0.0426 (Fisher's exact test), Q value = 0.14
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
9P GAIN MUTATED | 13 | 1 | 2 |
9P GAIN WILD-TYPE | 309 | 43 | 5 |
P value = 0.0102 (Fisher's exact test), Q value = 0.045
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
9P GAIN MUTATED | 15 | 11 |
9P GAIN WILD-TYPE | 277 | 578 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
9P GAIN MUTATED | 9 | 14 | 3 |
9P GAIN WILD-TYPE | 57 | 514 | 284 |
P value = 0.00131 (Fisher's exact test), Q value = 0.0081
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
9Q GAIN MUTATED | 5 | 8 | 6 | 5 |
9Q GAIN WILD-TYPE | 450 | 96 | 185 | 99 |
P value = 9e-05 (Fisher's exact test), Q value = 0.00078
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
9Q GAIN MUTATED | 5 | 8 | 8 | 3 |
9Q GAIN WILD-TYPE | 474 | 119 | 250 | 12 |
P value = 0.0425 (Fisher's exact test), Q value = 0.14
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
9Q GAIN MUTATED | 13 | 1 | 2 |
9Q GAIN WILD-TYPE | 309 | 43 | 5 |
P value = 0.045 (Fisher's exact test), Q value = 0.15
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
9Q GAIN MUTATED | 13 | 11 |
9Q GAIN WILD-TYPE | 279 | 578 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
9Q GAIN MUTATED | 9 | 13 | 2 |
9Q GAIN WILD-TYPE | 57 | 515 | 285 |
P value = 0.00533 (Fisher's exact test), Q value = 0.026
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
10P GAIN MUTATED | 12 | 8 | 7 | 3 |
10P GAIN WILD-TYPE | 467 | 119 | 251 | 12 |
P value = 0.0403 (Fisher's exact test), Q value = 0.14
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
10P GAIN MUTATED | 9 | 4 | 1 |
10P GAIN WILD-TYPE | 313 | 40 | 6 |
P value = 0.0714 (Fisher's exact test), Q value = 0.21
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
10Q GAIN MUTATED | 11 | 5 | 5 | 2 |
10Q GAIN WILD-TYPE | 468 | 122 | 253 | 13 |
P value = 0.0374 (Fisher's exact test), Q value = 0.13
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
10Q GAIN MUTATED | 7 | 3 | 1 |
10Q GAIN WILD-TYPE | 315 | 41 | 6 |
P value = 0.00652 (Fisher's exact test), Q value = 0.031
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
11P GAIN MUTATED | 18 | 9 | 17 | 12 |
11P GAIN WILD-TYPE | 437 | 95 | 174 | 92 |
P value = 0.00255 (Fisher's exact test), Q value = 0.014
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
11P GAIN MUTATED | 18 | 11 | 27 | 1 |
11P GAIN WILD-TYPE | 461 | 116 | 231 | 14 |
P value = 0.0373 (Fisher's exact test), Q value = 0.13
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
11P GAIN MUTATED | 32 | 11 |
11P GAIN WILD-TYPE | 513 | 78 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
11P GAIN MUTATED | 15 | 31 | 11 |
11P GAIN WILD-TYPE | 51 | 497 | 276 |
P value = 0.0636 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
11P GAIN MUTATED | 7 | 17.3 (16.6) |
11P GAIN WILD-TYPE | 99 | 31.7 (25.1) |
P value = 0.0536 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
11Q GAIN MUTATED | 55 | 57.0 (12.8) |
11Q GAIN WILD-TYPE | 820 | 60.3 (12.5) |
P value = 0.0357 (Fisher's exact test), Q value = 0.13
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
11Q GAIN MUTATED | 19 | 9 | 16 | 10 |
11Q GAIN WILD-TYPE | 436 | 95 | 175 | 94 |
P value = 0.0093 (Fisher's exact test), Q value = 0.041
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
11Q GAIN MUTATED | 19 | 11 | 25 | 0 |
11Q GAIN WILD-TYPE | 460 | 116 | 233 | 15 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
11Q GAIN MUTATED | 16 | 29 | 10 |
11Q GAIN WILD-TYPE | 50 | 499 | 277 |
P value = 0.0422 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
11Q GAIN MUTATED | 8 | 17.0 (15.3) |
11Q GAIN WILD-TYPE | 98 | 31.9 (25.2) |
P value = 0.0498 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
11Q GAIN MUTATED | 6 | 1985.3 (11.3) |
11Q GAIN WILD-TYPE | 68 | 1972.7 (16.0) |
P value = 0.0612 (Fisher's exact test), Q value = 0.19
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
12P GAIN MUTATED | 118 | 29 | 54 | 41 |
12P GAIN WILD-TYPE | 337 | 75 | 137 | 63 |
P value = 0.0122 (Fisher's exact test), Q value = 0.052
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
12P GAIN MUTATED | 87 | 21 | 3 |
12P GAIN WILD-TYPE | 235 | 23 | 4 |
P value = 0.00883 (Fisher's exact test), Q value = 0.04
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
12P GAIN MUTATED | 129 | 33 |
12P GAIN WILD-TYPE | 416 | 56 |
P value = 0.00558 (Fisher's exact test), Q value = 0.027
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
12P GAIN MUTATED | 66 | 186 |
12P GAIN WILD-TYPE | 226 | 403 |
P value = 0.0646 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
12P GAIN MUTATED | 50 | 84.2 (26.4) |
12P GAIN WILD-TYPE | 92 | 89.5 (20.5) |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
12P GAIN MUTATED | 19 | 121 | 112 |
12P GAIN WILD-TYPE | 47 | 407 | 175 |
P value = 0.0568 (Fisher's exact test), Q value = 0.17
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
12P GAIN MUTATED | 7 | 190 |
12P GAIN WILD-TYPE | 35 | 431 |
P value = 0.0636 (logrank test), Q value = 0.19
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
12Q GAIN MUTATED | 251 | 71 | 0.1 - 194.8 (28.2) |
12Q GAIN WILD-TYPE | 622 | 157 | 0.1 - 149.2 (37.3) |
P value = 0.035 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
12Q GAIN MUTATED | 118 | 29 | 57 | 42 |
12Q GAIN WILD-TYPE | 337 | 75 | 134 | 62 |
P value = 0.0691 (Fisher's exact test), Q value = 0.2
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
12Q GAIN MUTATED | 126 | 34 | 87 | 7 |
12Q GAIN WILD-TYPE | 353 | 93 | 171 | 8 |
P value = 0.00551 (Fisher's exact test), Q value = 0.027
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
12Q GAIN MUTATED | 88 | 21 | 4 |
12Q GAIN WILD-TYPE | 234 | 23 | 3 |
P value = 0.0131 (Fisher's exact test), Q value = 0.055
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
12Q GAIN MUTATED | 132 | 33 |
12Q GAIN WILD-TYPE | 413 | 56 |
P value = 0.00573 (Fisher's exact test), Q value = 0.028
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
12Q GAIN MUTATED | 67 | 189 |
12Q GAIN WILD-TYPE | 225 | 400 |
P value = 0.0646 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
12Q GAIN MUTATED | 50 | 84.2 (26.4) |
12Q GAIN WILD-TYPE | 92 | 89.5 (20.5) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
12Q GAIN MUTATED | 21 | 123 | 112 |
12Q GAIN WILD-TYPE | 45 | 405 | 175 |
P value = 0.0556 (Fisher's exact test), Q value = 0.17
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
12Q GAIN MUTATED | 7 | 193 |
12Q GAIN WILD-TYPE | 35 | 428 |
P value = 0.0134 (Fisher's exact test), Q value = 0.056
nPatients | NO | YES |
---|---|---|
ALL | 400 | 3 |
13Q GAIN MUTATED | 26 | 2 |
13Q GAIN WILD-TYPE | 374 | 1 |
P value = 0.00232 (Fisher's exact test), Q value = 0.013
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
13Q GAIN MUTATED | 2 | 22 | 29 |
13Q GAIN WILD-TYPE | 64 | 506 | 258 |
P value = 0.0435 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
14Q GAIN MUTATED | 38 | 56.4 (12.4) |
14Q GAIN WILD-TYPE | 837 | 60.3 (12.5) |
P value = 0.00178 (Fisher's exact test), Q value = 0.01
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
14Q GAIN MUTATED | 12 | 12 | 8 | 7 |
14Q GAIN WILD-TYPE | 443 | 92 | 183 | 97 |
P value = 0.00045 (Fisher's exact test), Q value = 0.0033
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
14Q GAIN MUTATED | 12 | 12 | 12 | 3 |
14Q GAIN WILD-TYPE | 467 | 115 | 246 | 12 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
14Q GAIN MUTATED | 20 | 16 | 3 |
14Q GAIN WILD-TYPE | 46 | 512 | 284 |
P value = 0.084 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
14Q GAIN MUTATED | 3 | 1989.0 (7.0) |
14Q GAIN WILD-TYPE | 71 | 1973.1 (16.0) |
P value = 0.00091 (Fisher's exact test), Q value = 0.0061
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
15Q GAIN MUTATED | 17 | 15 | 11 | 9 |
15Q GAIN WILD-TYPE | 438 | 89 | 180 | 95 |
P value = 0.00321 (Fisher's exact test), Q value = 0.017
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
15Q GAIN MUTATED | 17 | 15 | 19 | 1 |
15Q GAIN WILD-TYPE | 462 | 112 | 239 | 14 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
15Q GAIN MUTATED | 21 | 26 | 5 |
15Q GAIN WILD-TYPE | 45 | 502 | 282 |
P value = 0.0588 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
15Q GAIN MUTATED | 4 | 1987.5 (12.7) |
15Q GAIN WILD-TYPE | 70 | 1972.9 (15.9) |
P value = 0.0206 (logrank test), Q value = 0.081
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
16P GAIN MUTATED | 276 | 56 | 0.1 - 194.8 (30.6) |
16P GAIN WILD-TYPE | 597 | 172 | 0.1 - 149.2 (36.4) |
P value = 0.0117 (Wilcoxon-test), Q value = 0.05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
16P GAIN MUTATED | 279 | 61.6 (12.2) |
16P GAIN WILD-TYPE | 596 | 59.4 (12.6) |
P value = 0.00211 (Fisher's exact test), Q value = 0.012
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
16P GAIN MUTATED | 73 | 208 |
16P GAIN WILD-TYPE | 219 | 381 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
16P GAIN MUTATED | 21 | 107 | 153 |
16P GAIN WILD-TYPE | 45 | 421 | 134 |
P value = 0.0368 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
16P GAIN MUTATED | 2 | 5 | 29 | 238 |
16P GAIN WILD-TYPE | 0 | 10 | 92 | 481 |
P value = 0.00224 (logrank test), Q value = 0.013
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
16Q GAIN MUTATED | 263 | 49 | 0.1 - 194.8 (30.7) |
16Q GAIN WILD-TYPE | 610 | 179 | 0.1 - 149.2 (36.1) |
P value = 0.0294 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
16Q GAIN MUTATED | 266 | 61.5 (12.3) |
16Q GAIN WILD-TYPE | 609 | 59.5 (12.6) |
P value = 0.0102 (Fisher's exact test), Q value = 0.045
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
16Q GAIN MUTATED | 72 | 196 |
16Q GAIN WILD-TYPE | 220 | 393 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
16Q GAIN MUTATED | 21 | 99 | 148 |
16Q GAIN WILD-TYPE | 45 | 429 | 139 |
P value = 0.0234 (logrank test), Q value = 0.09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
17P GAIN MUTATED | 193 | 28 | 0.1 - 194.8 (25.4) |
17P GAIN WILD-TYPE | 680 | 200 | 0.1 - 152.0 (38.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
17P GAIN MUTATED | 132 | 19 | 23 | 7 |
17P GAIN WILD-TYPE | 323 | 85 | 168 | 97 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
17P GAIN MUTATED | 141 | 26 | 27 | 2 |
17P GAIN WILD-TYPE | 338 | 101 | 231 | 13 |
P value = 0.0156 (Fisher's exact test), Q value = 0.064
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
17P GAIN MUTATED | 32 | 11 | 1 |
17P GAIN WILD-TYPE | 290 | 33 | 6 |
P value = 0.0101 (Fisher's exact test), Q value = 0.044
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
17P GAIN MUTATED | 68 | 3 |
17P GAIN WILD-TYPE | 477 | 86 |
P value = 0.000422 (Fisher's exact test), Q value = 0.0032
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
17P GAIN MUTATED | 45 | 152 |
17P GAIN WILD-TYPE | 247 | 437 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
17P GAIN MUTATED | 0 | 25 | 172 |
17P GAIN WILD-TYPE | 66 | 503 | 115 |
P value = 0.00721 (Fisher's exact test), Q value = 0.033
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
17P GAIN MUTATED | 2 | 6 | 33 | 148 |
17P GAIN WILD-TYPE | 0 | 9 | 88 | 571 |
P value = 0.0103 (Fisher's exact test), Q value = 0.045
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
17P GAIN MUTATED | 4 | 169 |
17P GAIN WILD-TYPE | 38 | 452 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
17Q GAIN MUTATED | 140 | 20 | 33 | 11 |
17Q GAIN WILD-TYPE | 315 | 84 | 158 | 93 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
17Q GAIN MUTATED | 149 | 29 | 41 | 2 |
17Q GAIN WILD-TYPE | 330 | 98 | 217 | 13 |
P value = 0.00153 (Fisher's exact test), Q value = 0.0092
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
17Q GAIN MUTATED | 43 | 12 | 4 |
17Q GAIN WILD-TYPE | 279 | 32 | 3 |
P value = 0.045 (Fisher's exact test), Q value = 0.15
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
17Q GAIN MUTATED | 79 | 6 |
17Q GAIN WILD-TYPE | 466 | 83 |
P value = 0.0106 (Fisher's exact test), Q value = 0.046
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
17Q GAIN MUTATED | 58 | 164 |
17Q GAIN WILD-TYPE | 234 | 425 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
17Q GAIN MUTATED | 0 | 31 | 191 |
17Q GAIN WILD-TYPE | 66 | 497 | 96 |
P value = 0.0097 (Fisher's exact test), Q value = 0.043
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
17Q GAIN MUTATED | 2 | 6 | 38 | 167 |
17Q GAIN WILD-TYPE | 0 | 9 | 83 | 552 |
P value = 0.034 (Fisher's exact test), Q value = 0.12
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
17Q GAIN MUTATED | 6 | 186 |
17Q GAIN WILD-TYPE | 36 | 435 |
P value = 0.0223 (logrank test), Q value = 0.086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
18P GAIN MUTATED | 54 | 8 | 0.5 - 152.0 (47.7) |
18P GAIN WILD-TYPE | 819 | 220 | 0.1 - 194.8 (33.8) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
18P GAIN MUTATED | 17 | 25 | 12 |
18P GAIN WILD-TYPE | 49 | 503 | 275 |
P value = 0.0715 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
18P GAIN MUTATED | 0 | 0 | 2 | 51 |
18P GAIN WILD-TYPE | 2 | 15 | 119 | 668 |
P value = 0.00698 (logrank test), Q value = 0.032
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
18Q GAIN MUTATED | 50 | 6 | 0.5 - 152.0 (48.9) |
18Q GAIN WILD-TYPE | 823 | 222 | 0.1 - 194.8 (33.5) |
P value = 0.0262 (Wilcoxon-test), Q value = 0.098
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
18Q GAIN MUTATED | 9 | 97.8 (6.7) |
18Q GAIN WILD-TYPE | 133 | 86.9 (23.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
18Q GAIN MUTATED | 16 | 25 | 9 |
18Q GAIN WILD-TYPE | 50 | 503 | 278 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
19P GAIN MUTATED | 21 | 15 | 18 | 21 |
19P GAIN WILD-TYPE | 434 | 89 | 173 | 83 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
19P GAIN MUTATED | 22 | 15 | 35 | 3 |
19P GAIN WILD-TYPE | 457 | 112 | 223 | 12 |
P value = 0.00372 (Fisher's exact test), Q value = 0.02
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
19P GAIN MUTATED | 46 | 17 |
19P GAIN WILD-TYPE | 499 | 72 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
19P GAIN MUTATED | 19 | 52 | 4 |
19P GAIN WILD-TYPE | 47 | 476 | 283 |
P value = 0.00103 (Fisher's exact test), Q value = 0.0067
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
19P GAIN MUTATED | 0 | 2 | 1 | 72 |
19P GAIN WILD-TYPE | 2 | 13 | 120 | 647 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
19Q GAIN MUTATED | 22 | 15 | 20 | 21 |
19Q GAIN WILD-TYPE | 433 | 89 | 171 | 83 |
P value = 6e-05 (Fisher's exact test), Q value = 0.00053
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
19Q GAIN MUTATED | 23 | 17 | 36 | 2 |
19Q GAIN WILD-TYPE | 456 | 110 | 222 | 13 |
P value = 0.00117 (Fisher's exact test), Q value = 0.0074
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
19Q GAIN MUTATED | 48 | 19 |
19Q GAIN WILD-TYPE | 497 | 70 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
19Q GAIN MUTATED | 17 | 57 | 4 |
19Q GAIN WILD-TYPE | 49 | 471 | 283 |
P value = 0.00086 (Fisher's exact test), Q value = 0.0058
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
19Q GAIN MUTATED | 0 | 1 | 1 | 76 |
19Q GAIN WILD-TYPE | 2 | 14 | 120 | 643 |
P value = 0.00664 (Fisher's exact test), Q value = 0.031
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
20P GAIN MUTATED | 98 | 31 | 55 | 38 |
20P GAIN WILD-TYPE | 357 | 73 | 136 | 66 |
P value = 0.00326 (Fisher's exact test), Q value = 0.017
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
20P GAIN MUTATED | 106 | 37 | 81 | 8 |
20P GAIN WILD-TYPE | 373 | 90 | 177 | 7 |
P value = 0.072 (Fisher's exact test), Q value = 0.21
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
20P GAIN MUTATED | 75 | 16 | 3 |
20P GAIN WILD-TYPE | 247 | 28 | 4 |
P value = 0.0344 (Fisher's exact test), Q value = 0.12
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
20P GAIN MUTATED | 126 | 30 |
20P GAIN WILD-TYPE | 419 | 59 |
P value = 0.00115 (Fisher's exact test), Q value = 0.0074
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
20P GAIN MUTATED | 57 | 175 |
20P GAIN WILD-TYPE | 235 | 414 |
P value = 3e-04 (Fisher's exact test), Q value = 0.0023
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
20P GAIN MUTATED | 21 | 113 | 98 |
20P GAIN WILD-TYPE | 45 | 415 | 189 |
P value = 0.0052 (Fisher's exact test), Q value = 0.026
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
20Q GAIN MUTATED | 99 | 31 | 58 | 38 |
20Q GAIN WILD-TYPE | 356 | 73 | 133 | 66 |
P value = 0.00595 (Fisher's exact test), Q value = 0.029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
20Q GAIN MUTATED | 108 | 37 | 84 | 7 |
20Q GAIN WILD-TYPE | 371 | 90 | 174 | 8 |
P value = 0.026 (Fisher's exact test), Q value = 0.097
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
20Q GAIN MUTATED | 76 | 18 | 3 |
20Q GAIN WILD-TYPE | 246 | 26 | 4 |
P value = 0.0645 (Fisher's exact test), Q value = 0.19
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
20Q GAIN MUTATED | 130 | 30 |
20Q GAIN WILD-TYPE | 415 | 59 |
P value = 0.00357 (Fisher's exact test), Q value = 0.019
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
20Q GAIN MUTATED | 60 | 176 |
20Q GAIN WILD-TYPE | 232 | 413 |
P value = 2e-04 (Fisher's exact test), Q value = 0.0017
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
20Q GAIN MUTATED | 21 | 115 | 100 |
20Q GAIN WILD-TYPE | 45 | 413 | 187 |
P value = 0.0394 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
21Q GAIN MUTATED | 14 | 95.7 (9.4) |
21Q GAIN WILD-TYPE | 128 | 86.7 (23.7) |
P value = 0.0534 (Fisher's exact test), Q value = 0.17
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
21Q GAIN MUTATED | 1 | 1 | 5 | 65 |
21Q GAIN WILD-TYPE | 1 | 14 | 116 | 654 |
P value = 0.0153 (Fisher's exact test), Q value = 0.063
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
22Q GAIN MUTATED | 23 | 13 | 15 | 12 |
22Q GAIN WILD-TYPE | 432 | 91 | 176 | 92 |
P value = 0.00173 (Fisher's exact test), Q value = 0.01
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
22Q GAIN MUTATED | 23 | 14 | 23 | 4 |
22Q GAIN WILD-TYPE | 456 | 113 | 235 | 11 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
22Q GAIN MUTATED | 19 | 40 | 5 |
22Q GAIN WILD-TYPE | 47 | 488 | 282 |
P value = 0.0194 (Fisher's exact test), Q value = 0.077
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
XP GAIN MUTATED | 73 | 12 | 14 | 15 |
XP GAIN WILD-TYPE | 382 | 92 | 177 | 89 |
P value = 0.0377 (Fisher's exact test), Q value = 0.13
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
XP GAIN MUTATED | 79 | 18 | 24 | 3 |
XP GAIN WILD-TYPE | 400 | 109 | 234 | 12 |
P value = 0.0073 (Fisher's exact test), Q value = 0.034
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
XP GAIN MUTATED | 28 | 96 |
XP GAIN WILD-TYPE | 264 | 493 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
XP GAIN MUTATED | 7 | 30 | 87 |
XP GAIN WILD-TYPE | 59 | 498 | 200 |
P value = 0.0502 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
XP GAIN MUTATED | 16 | 1967.7 (14.3) |
XP GAIN WILD-TYPE | 58 | 1975.4 (16.1) |
P value = 0.0295 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
XP GAIN MUTATED | 2 | 3 | 17 | 96 |
XP GAIN WILD-TYPE | 0 | 12 | 104 | 623 |
P value = 0.0203 (Fisher's exact test), Q value = 0.08
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
XQ GAIN MUTATED | 73 | 12 | 14 | 15 |
XQ GAIN WILD-TYPE | 382 | 92 | 177 | 89 |
P value = 0.0744 (Fisher's exact test), Q value = 0.21
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
XQ GAIN MUTATED | 79 | 19 | 25 | 2 |
XQ GAIN WILD-TYPE | 400 | 108 | 233 | 13 |
P value = 0.0104 (Fisher's exact test), Q value = 0.045
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
XQ GAIN MUTATED | 29 | 96 |
XQ GAIN WILD-TYPE | 263 | 493 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
XQ GAIN MUTATED | 7 | 30 | 88 |
XQ GAIN WILD-TYPE | 59 | 498 | 199 |
P value = 0.0352 (Fisher's exact test), Q value = 0.12
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
XQ GAIN MUTATED | 2 | 2 | 19 | 96 |
XQ GAIN WILD-TYPE | 0 | 13 | 102 | 623 |
P value = 0.0183 (Wilcoxon-test), Q value = 0.073
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
1P LOSS MUTATED | 145 | 57.6 (14.1) |
1P LOSS WILD-TYPE | 730 | 60.6 (12.1) |
P value = 6e-05 (Fisher's exact test), Q value = 0.00053
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
1P LOSS MUTATED | 56 | 34 | 32 | 16 |
1P LOSS WILD-TYPE | 399 | 70 | 159 | 88 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
1P LOSS MUTATED | 61 | 38 | 41 | 5 |
1P LOSS WILD-TYPE | 418 | 89 | 217 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
1P LOSS MUTATED | 53 | 60 | 32 |
1P LOSS WILD-TYPE | 13 | 468 | 255 |
P value = 0.0388 (logrank test), Q value = 0.13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
1Q LOSS MUTATED | 109 | 25 | 0.1 - 152.0 (49.3) |
1Q LOSS WILD-TYPE | 764 | 203 | 0.1 - 194.8 (32.8) |
P value = 0.000693 (Wilcoxon-test), Q value = 0.0049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
1Q LOSS MUTATED | 110 | 55.8 (14.2) |
1Q LOSS WILD-TYPE | 765 | 60.7 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
1Q LOSS MUTATED | 42 | 30 | 21 | 12 |
1Q LOSS WILD-TYPE | 413 | 74 | 170 | 92 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
1Q LOSS MUTATED | 45 | 31 | 30 | 4 |
1Q LOSS WILD-TYPE | 434 | 96 | 228 | 11 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
1Q LOSS MUTATED | 52 | 37 | 21 |
1Q LOSS WILD-TYPE | 14 | 491 | 266 |
P value = 0.00434 (logrank test), Q value = 0.023
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
2P LOSS MUTATED | 63 | 12 | 2.5 - 152.0 (66.5) |
2P LOSS WILD-TYPE | 810 | 216 | 0.1 - 194.8 (31.8) |
P value = 4.59e-05 (Wilcoxon-test), Q value = 0.00043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
2P LOSS MUTATED | 64 | 53.4 (14.2) |
2P LOSS WILD-TYPE | 811 | 60.7 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
2P LOSS MUTATED | 20 | 24 | 14 | 5 |
2P LOSS WILD-TYPE | 435 | 80 | 177 | 99 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
2P LOSS MUTATED | 21 | 25 | 18 | 1 |
2P LOSS WILD-TYPE | 458 | 102 | 240 | 14 |
P value = 0.0701 (Fisher's exact test), Q value = 0.2
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
2P LOSS MUTATED | 42 | 2 |
2P LOSS WILD-TYPE | 503 | 87 |
P value = 0.0463 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
2P LOSS MUTATED | 9 | 97.8 (4.4) |
2P LOSS WILD-TYPE | 133 | 86.9 (23.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
2P LOSS MUTATED | 46 | 14 | 5 |
2P LOSS WILD-TYPE | 20 | 514 | 282 |
P value = 0.00302 (logrank test), Q value = 0.017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
2Q LOSS MUTATED | 61 | 11 | 2.5 - 152.0 (66.5) |
2Q LOSS WILD-TYPE | 812 | 217 | 0.1 - 194.8 (31.8) |
P value = 2.61e-05 (Wilcoxon-test), Q value = 0.00027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
2Q LOSS MUTATED | 62 | 53.0 (14.3) |
2Q LOSS WILD-TYPE | 813 | 60.7 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
2Q LOSS MUTATED | 19 | 24 | 14 | 5 |
2Q LOSS WILD-TYPE | 436 | 80 | 177 | 99 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
2Q LOSS MUTATED | 20 | 24 | 18 | 1 |
2Q LOSS WILD-TYPE | 459 | 103 | 240 | 14 |
P value = 0.07 (Fisher's exact test), Q value = 0.2
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
2Q LOSS MUTATED | 41 | 2 |
2Q LOSS WILD-TYPE | 504 | 87 |
P value = 0.0463 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
2Q LOSS MUTATED | 9 | 97.8 (4.4) |
2Q LOSS WILD-TYPE | 133 | 86.9 (23.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
2Q LOSS MUTATED | 46 | 14 | 3 |
2Q LOSS WILD-TYPE | 20 | 514 | 284 |
P value = 0.00243 (logrank test), Q value = 0.014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
3P LOSS MUTATED | 411 | 135 | 0.1 - 141.7 (39.0) |
3P LOSS WILD-TYPE | 462 | 93 | 0.1 - 194.8 (29.7) |
P value = 0.00045 (Fisher's exact test), Q value = 0.0033
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
3P LOSS MUTATED | 191 | 50 | 113 | 57 |
3P LOSS WILD-TYPE | 264 | 54 | 78 | 47 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00038
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
3P LOSS MUTATED | 195 | 62 | 151 | 4 |
3P LOSS WILD-TYPE | 284 | 65 | 107 | 11 |
P value = 0.0506 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
3P LOSS MUTATED | 178 | 17 | 2 |
3P LOSS WILD-TYPE | 144 | 27 | 5 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
3P LOSS MUTATED | 9 | 381 | 22 |
3P LOSS WILD-TYPE | 57 | 147 | 265 |
P value = 0.0264 (Wilcoxon-test), Q value = 0.098
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
3P LOSS MUTATED | 16 | 1981.4 (18.7) |
3P LOSS WILD-TYPE | 58 | 1971.6 (14.6) |
P value = 0.00068 (Fisher's exact test), Q value = 0.0048
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
3P LOSS MUTATED | 0 | 6 | 39 | 360 |
3P LOSS WILD-TYPE | 2 | 9 | 82 | 359 |
P value = 0.0446 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
3Q LOSS MUTATED | 124 | 62.4 (13.1) |
3Q LOSS WILD-TYPE | 751 | 59.8 (12.4) |
P value = 0.0397 (Fisher's exact test), Q value = 0.13
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
3Q LOSS MUTATED | 31 | 93 |
3Q LOSS WILD-TYPE | 261 | 496 |
P value = 0.0164 (Fisher's exact test), Q value = 0.066
nPatients | NO | YES |
---|---|---|
ALL | 400 | 3 |
3Q LOSS MUTATED | 29 | 2 |
3Q LOSS WILD-TYPE | 371 | 1 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
3Q LOSS MUTATED | 8 | 109 | 7 |
3Q LOSS WILD-TYPE | 58 | 419 | 280 |
P value = 0.0395 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
3Q LOSS MUTATED | 0 | 1 | 8 | 112 |
3Q LOSS WILD-TYPE | 2 | 14 | 113 | 607 |
P value = 5.05e-12 (logrank test), Q value = 1.9e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
4P LOSS MUTATED | 97 | 51 | 0.5 - 133.7 (27.6) |
4P LOSS WILD-TYPE | 776 | 177 | 0.1 - 194.8 (35.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
4P LOSS MUTATED | 25 | 7 | 40 | 23 |
4P LOSS WILD-TYPE | 430 | 97 | 151 | 81 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
4P LOSS MUTATED | 27 | 11 | 55 | 5 |
4P LOSS WILD-TYPE | 452 | 116 | 203 | 10 |
P value = 0.00195 (Fisher's exact test), Q value = 0.011
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
4P LOSS MUTATED | 36 | 14 | 1 |
4P LOSS WILD-TYPE | 286 | 30 | 6 |
P value = 0.0146 (Fisher's exact test), Q value = 0.06
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
4P LOSS MUTATED | 61 | 19 |
4P LOSS WILD-TYPE | 484 | 70 |
P value = 0.068 (Fisher's exact test), Q value = 0.2
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
4P LOSS MUTATED | 41 | 57 |
4P LOSS WILD-TYPE | 251 | 532 |
P value = 0.00185 (Fisher's exact test), Q value = 0.011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
4P LOSS MUTATED | 1 | 72 | 25 |
4P LOSS WILD-TYPE | 65 | 456 | 262 |
P value = 9.44e-14 (logrank test), Q value = 1.1e-10
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
4Q LOSS MUTATED | 91 | 49 | 1.0 - 133.7 (20.9) |
4Q LOSS WILD-TYPE | 782 | 179 | 0.1 - 194.8 (36.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
4Q LOSS MUTATED | 20 | 7 | 37 | 25 |
4Q LOSS WILD-TYPE | 435 | 97 | 154 | 79 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
4Q LOSS MUTATED | 22 | 12 | 52 | 6 |
4Q LOSS WILD-TYPE | 457 | 115 | 206 | 9 |
P value = 0.00138 (Fisher's exact test), Q value = 0.0084
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
4Q LOSS MUTATED | 31 | 13 | 1 |
4Q LOSS WILD-TYPE | 291 | 31 | 6 |
P value = 0.000616 (Fisher's exact test), Q value = 0.0044
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
4Q LOSS MUTATED | 54 | 21 |
4Q LOSS WILD-TYPE | 491 | 68 |
P value = 0.00847 (Fisher's exact test), Q value = 0.038
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
4Q LOSS MUTATED | 1 | 65 | 26 |
4Q LOSS WILD-TYPE | 65 | 463 | 261 |
P value = 0.0785 (Fisher's exact test), Q value = 0.22
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
4Q LOSS MUTATED | 0 | 3 | 6 | 77 |
4Q LOSS WILD-TYPE | 2 | 12 | 115 | 642 |
P value = 0.052 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
5P LOSS MUTATED | 23 | 11 | 2.8 - 152.0 (24.8) |
5P LOSS WILD-TYPE | 850 | 217 | 0.1 - 194.8 (35.1) |
P value = 0.00256 (Wilcoxon-test), Q value = 0.014
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
5P LOSS MUTATED | 24 | 51.3 (14.5) |
5P LOSS WILD-TYPE | 851 | 60.4 (12.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
5P LOSS MUTATED | 2 | 9 | 5 | 7 |
5P LOSS WILD-TYPE | 453 | 95 | 186 | 97 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
5P LOSS MUTATED | 2 | 10 | 10 | 2 |
5P LOSS WILD-TYPE | 477 | 117 | 248 | 13 |
P value = 0.0248 (Fisher's exact test), Q value = 0.094
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
5P LOSS MUTATED | 12 | 3 | 2 |
5P LOSS WILD-TYPE | 310 | 41 | 5 |
P value = 0.045 (Fisher's exact test), Q value = 0.15
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
5P LOSS MUTATED | 13 | 11 |
5P LOSS WILD-TYPE | 279 | 578 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
5P LOSS MUTATED | 10 | 7 | 7 |
5P LOSS WILD-TYPE | 56 | 521 | 280 |
P value = 0.0793 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
5P LOSS MUTATED | 5 | 15.8 (15.7) |
5P LOSS WILD-TYPE | 101 | 31.5 (25.0) |
P value = 0.0863 (Fisher's exact test), Q value = 0.24
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
5P LOSS MUTATED | 3 | 14 |
5P LOSS WILD-TYPE | 39 | 607 |
P value = 0.000184 (Wilcoxon-test), Q value = 0.0016
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
5Q LOSS MUTATED | 22 | 48.5 (15.1) |
5Q LOSS WILD-TYPE | 853 | 60.4 (12.3) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
5Q LOSS MUTATED | 2 | 9 | 6 | 4 |
5Q LOSS WILD-TYPE | 453 | 95 | 185 | 100 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
5Q LOSS MUTATED | 2 | 9 | 9 | 2 |
5Q LOSS WILD-TYPE | 477 | 118 | 249 | 13 |
P value = 0.0495 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
5Q LOSS MUTATED | 10 | 4 | 1 |
5Q LOSS WILD-TYPE | 312 | 40 | 6 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
5Q LOSS MUTATED | 10 | 5 | 7 |
5Q LOSS WILD-TYPE | 56 | 523 | 280 |
P value = 0.037 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
5Q LOSS MUTATED | 4 | 12.2 (15.6) |
5Q LOSS WILD-TYPE | 102 | 31.5 (24.9) |
P value = 0.0631 (Fisher's exact test), Q value = 0.19
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
5Q LOSS MUTATED | 3 | 12 |
5Q LOSS WILD-TYPE | 39 | 609 |
P value = 0.0737 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
6P LOSS MUTATED | 170 | 58.1 (14.7) |
6P LOSS WILD-TYPE | 705 | 60.6 (11.9) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
6P LOSS MUTATED | 59 | 36 | 47 | 28 |
6P LOSS WILD-TYPE | 396 | 68 | 144 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
6P LOSS MUTATED | 61 | 39 | 67 | 5 |
6P LOSS WILD-TYPE | 418 | 88 | 191 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
6P LOSS MUTATED | 50 | 101 | 21 |
6P LOSS WILD-TYPE | 16 | 427 | 266 |
P value = 0.00025 (Fisher's exact test), Q value = 0.002
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
6P LOSS MUTATED | 0 | 4 | 8 | 153 |
6P LOSS WILD-TYPE | 2 | 11 | 113 | 566 |
P value = 0.0738 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
6Q LOSS MUTATED | 204 | 58.3 (14.1) |
6Q LOSS WILD-TYPE | 671 | 60.7 (11.9) |
P value = 6e-05 (Fisher's exact test), Q value = 0.00053
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
6Q LOSS MUTATED | 82 | 40 | 50 | 32 |
6Q LOSS WILD-TYPE | 373 | 64 | 141 | 72 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
6Q LOSS MUTATED | 83 | 42 | 74 | 7 |
6Q LOSS WILD-TYPE | 396 | 85 | 184 | 8 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
6Q LOSS MUTATED | 51 | 129 | 26 |
6Q LOSS WILD-TYPE | 15 | 399 | 261 |
P value = 0.00022 (Fisher's exact test), Q value = 0.0018
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
6Q LOSS MUTATED | 0 | 6 | 12 | 180 |
6Q LOSS WILD-TYPE | 2 | 9 | 109 | 539 |
P value = 0.089 (logrank test), Q value = 0.25
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
7P LOSS MUTATED | 4 | 2 | 1.4 - 84.9 (9.5) |
7P LOSS WILD-TYPE | 869 | 226 | 0.1 - 194.8 (34.9) |
P value = 0.0498 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
7P LOSS MUTATED | 1 | 2 | 0 |
7P LOSS WILD-TYPE | 321 | 42 | 7 |
P value = 0.089 (logrank test), Q value = 0.25
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
7Q LOSS MUTATED | 4 | 2 | 1.4 - 84.9 (9.5) |
7Q LOSS WILD-TYPE | 869 | 226 | 0.1 - 194.8 (34.9) |
P value = 0.0509 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
7Q LOSS MUTATED | 1 | 2 | 0 |
7Q LOSS WILD-TYPE | 321 | 42 | 7 |
P value = 0.0151 (logrank test), Q value = 0.062
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
8P LOSS MUTATED | 164 | 59 | 0.1 - 137.1 (39.2) |
8P LOSS WILD-TYPE | 709 | 169 | 0.1 - 194.8 (33.2) |
P value = 0.0236 (Fisher's exact test), Q value = 0.09
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
8P LOSS MUTATED | 70 | 21 | 42 | 28 |
8P LOSS WILD-TYPE | 385 | 83 | 149 | 76 |
P value = 0.0158 (Fisher's exact test), Q value = 0.064
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
8P LOSS MUTATED | 73 | 24 | 63 | 4 |
8P LOSS WILD-TYPE | 406 | 103 | 195 | 11 |
P value = 0.0572 (Fisher's exact test), Q value = 0.17
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
8P LOSS MUTATED | 119 | 28 |
8P LOSS WILD-TYPE | 426 | 61 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
8P LOSS MUTATED | 10 | 138 | 16 |
8P LOSS WILD-TYPE | 56 | 390 | 271 |
P value = 0.00498 (Fisher's exact test), Q value = 0.025
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
8P LOSS MUTATED | 0 | 6 | 12 | 144 |
8P LOSS WILD-TYPE | 2 | 9 | 109 | 575 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
8Q LOSS MUTATED | 9 | 69 | 9 |
8Q LOSS WILD-TYPE | 57 | 459 | 278 |
P value = 2.75e-12 (logrank test), Q value = 1.6e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
9P LOSS MUTATED | 189 | 89 | 0.5 - 141.7 (36.2) |
9P LOSS WILD-TYPE | 684 | 139 | 0.1 - 194.8 (34.4) |
P value = 0.079 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
9P LOSS MUTATED | 190 | 61.4 (12.0) |
9P LOSS WILD-TYPE | 685 | 59.8 (12.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
9P LOSS MUTATED | 65 | 15 | 65 | 44 |
9P LOSS WILD-TYPE | 390 | 89 | 126 | 60 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
9P LOSS MUTATED | 69 | 22 | 93 | 8 |
9P LOSS WILD-TYPE | 410 | 105 | 165 | 7 |
P value = 0.00502 (Fisher's exact test), Q value = 0.025
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
9P LOSS MUTATED | 71 | 19 | 3 |
9P LOSS WILD-TYPE | 251 | 25 | 4 |
P value = 0.000356 (Fisher's exact test), Q value = 0.0027
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
9P LOSS MUTATED | 125 | 37 |
9P LOSS WILD-TYPE | 420 | 52 |
P value = 0.00208 (Wilcoxon-test), Q value = 0.012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
9P LOSS MUTATED | 28 | 76.8 (31.7) |
9P LOSS WILD-TYPE | 114 | 90.3 (19.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
9P LOSS MUTATED | 10 | 149 | 33 |
9P LOSS WILD-TYPE | 56 | 379 | 254 |
P value = 0.0134 (Fisher's exact test), Q value = 0.056
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
9P LOSS MUTATED | 0 | 3 | 14 | 170 |
9P LOSS WILD-TYPE | 2 | 12 | 107 | 549 |
P value = 3.54e-10 (logrank test), Q value = 1e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
9Q LOSS MUTATED | 191 | 86 | 0.5 - 141.7 (36.2) |
9Q LOSS WILD-TYPE | 682 | 142 | 0.1 - 194.8 (34.3) |
P value = 0.0734 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
9Q LOSS MUTATED | 192 | 61.4 (12.2) |
9Q LOSS WILD-TYPE | 683 | 59.8 (12.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
9Q LOSS MUTATED | 63 | 19 | 68 | 42 |
9Q LOSS WILD-TYPE | 392 | 85 | 123 | 62 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
9Q LOSS MUTATED | 66 | 23 | 99 | 6 |
9Q LOSS WILD-TYPE | 413 | 104 | 159 | 9 |
P value = 0.0146 (Fisher's exact test), Q value = 0.06
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
9Q LOSS MUTATED | 73 | 18 | 3 |
9Q LOSS WILD-TYPE | 249 | 26 | 4 |
P value = 0.00107 (Fisher's exact test), Q value = 0.0069
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
9Q LOSS MUTATED | 128 | 36 |
9Q LOSS WILD-TYPE | 417 | 53 |
P value = 0.00132 (Wilcoxon-test), Q value = 0.0082
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
9Q LOSS MUTATED | 25 | 74.8 (33.1) |
9Q LOSS WILD-TYPE | 117 | 90.3 (19.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
9Q LOSS MUTATED | 11 | 150 | 33 |
9Q LOSS WILD-TYPE | 55 | 378 | 254 |
P value = 0.0113 (Fisher's exact test), Q value = 0.048
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
9Q LOSS MUTATED | 0 | 3 | 14 | 172 |
9Q LOSS WILD-TYPE | 2 | 12 | 107 | 547 |
P value = 0.0621 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
10P LOSS MUTATED | 130 | 57.7 (14.6) |
10P LOSS WILD-TYPE | 745 | 60.6 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
10P LOSS MUTATED | 42 | 26 | 42 | 19 |
10P LOSS WILD-TYPE | 413 | 78 | 149 | 85 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
10P LOSS MUTATED | 44 | 28 | 54 | 5 |
10P LOSS WILD-TYPE | 435 | 99 | 204 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
10P LOSS MUTATED | 48 | 67 | 16 |
10P LOSS WILD-TYPE | 18 | 461 | 271 |
P value = 0.035 (Wilcoxon-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
10Q LOSS MUTATED | 154 | 57.9 (14.2) |
10Q LOSS WILD-TYPE | 721 | 60.6 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
10Q LOSS MUTATED | 51 | 32 | 48 | 24 |
10Q LOSS WILD-TYPE | 404 | 72 | 143 | 80 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
10Q LOSS MUTATED | 53 | 34 | 62 | 7 |
10Q LOSS WILD-TYPE | 426 | 93 | 196 | 8 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
10Q LOSS MUTATED | 49 | 89 | 18 |
10Q LOSS WILD-TYPE | 17 | 439 | 269 |
P value = 0.00492 (logrank test), Q value = 0.025
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
11P LOSS MUTATED | 42 | 16 | 1.0 - 102.8 (21.6) |
11P LOSS WILD-TYPE | 831 | 212 | 0.1 - 194.8 (35.9) |
P value = 0.0337 (Wilcoxon-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
11P LOSS MUTATED | 42 | 63.9 (10.8) |
11P LOSS WILD-TYPE | 833 | 59.9 (12.6) |
P value = 0.00129 (Fisher's exact test), Q value = 0.008
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
11P LOSS MUTATED | 11 | 10 | 11 | 9 |
11P LOSS WILD-TYPE | 444 | 94 | 180 | 95 |
P value = 0.00078 (Fisher's exact test), Q value = 0.0053
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
11P LOSS MUTATED | 11 | 10 | 21 | 1 |
11P LOSS WILD-TYPE | 468 | 117 | 237 | 14 |
P value = 0.00107 (Fisher's exact test), Q value = 0.0069
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
11P LOSS MUTATED | 13 | 7 | 2 |
11P LOSS WILD-TYPE | 309 | 37 | 5 |
P value = 0.0161 (Fisher's exact test), Q value = 0.065
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
11P LOSS MUTATED | 7 | 18 | 18 |
11P LOSS WILD-TYPE | 59 | 510 | 269 |
P value = 0.000416 (logrank test), Q value = 0.0032
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
11Q LOSS MUTATED | 51 | 21 | 0.4 - 123.6 (19.7) |
11Q LOSS WILD-TYPE | 822 | 207 | 0.1 - 194.8 (36.1) |
P value = 0.0146 (Wilcoxon-test), Q value = 0.06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
11Q LOSS MUTATED | 51 | 63.9 (11.6) |
11Q LOSS WILD-TYPE | 824 | 59.9 (12.5) |
P value = 9e-05 (Fisher's exact test), Q value = 0.00078
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
11Q LOSS MUTATED | 12 | 9 | 18 | 12 |
11Q LOSS WILD-TYPE | 443 | 95 | 173 | 92 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00038
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
11Q LOSS MUTATED | 12 | 10 | 29 | 1 |
11Q LOSS WILD-TYPE | 467 | 117 | 229 | 14 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
11Q LOSS MUTATED | 18 | 10 | 3 |
11Q LOSS WILD-TYPE | 304 | 34 | 4 |
P value = 0.0459 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
11Q LOSS MUTATED | 13 | 80.0 (27.4) |
11Q LOSS WILD-TYPE | 129 | 88.4 (22.3) |
P value = 0.0316 (Fisher's exact test), Q value = 0.11
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
11Q LOSS MUTATED | 7 | 23 | 22 |
11Q LOSS WILD-TYPE | 59 | 505 | 265 |
P value = 0.0506 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
12P LOSS MUTATED | 1 | 2 | 0 |
12P LOSS WILD-TYPE | 321 | 42 | 7 |
P value = 0.0549 (Fisher's exact test), Q value = 0.17
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
12Q LOSS MUTATED | 1 | 0 | 2 | 1 |
12Q LOSS WILD-TYPE | 478 | 127 | 256 | 14 |
P value = 0.0366 (logrank test), Q value = 0.13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
13Q LOSS MUTATED | 135 | 50 | 0.2 - 152.0 (38.6) |
13Q LOSS WILD-TYPE | 738 | 178 | 0.1 - 194.8 (34.2) |
P value = 0.000117 (Wilcoxon-test), Q value = 0.001
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
13Q LOSS MUTATED | 137 | 55.5 (14.9) |
13Q LOSS WILD-TYPE | 738 | 61.0 (11.8) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
13Q LOSS MUTATED | 43 | 21 | 44 | 28 |
13Q LOSS WILD-TYPE | 412 | 83 | 147 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
13Q LOSS MUTATED | 45 | 23 | 60 | 9 |
13Q LOSS WILD-TYPE | 434 | 104 | 198 | 6 |
P value = 0.0164 (Fisher's exact test), Q value = 0.066
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
13Q LOSS MUTATED | 63 | 14 | 4 |
13Q LOSS WILD-TYPE | 259 | 30 | 3 |
P value = 0.0175 (Fisher's exact test), Q value = 0.07
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
13Q LOSS MUTATED | 58 | 79 |
13Q LOSS WILD-TYPE | 234 | 510 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
13Q LOSS MUTATED | 43 | 71 | 23 |
13Q LOSS WILD-TYPE | 23 | 457 | 264 |
P value = 1.38e-09 (logrank test), Q value = 3.2e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
14Q LOSS MUTATED | 264 | 106 | 0.1 - 133.7 (31.5) |
14Q LOSS WILD-TYPE | 609 | 122 | 0.1 - 194.8 (36.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
14Q LOSS MUTATED | 98 | 29 | 78 | 54 |
14Q LOSS WILD-TYPE | 357 | 75 | 113 | 50 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
14Q LOSS MUTATED | 105 | 39 | 117 | 4 |
14Q LOSS WILD-TYPE | 374 | 88 | 141 | 11 |
P value = 0.00926 (Fisher's exact test), Q value = 0.041
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
14Q LOSS MUTATED | 102 | 23 | 4 |
14Q LOSS WILD-TYPE | 220 | 21 | 3 |
P value = 4.21e-05 (Fisher's exact test), Q value = 4e-04
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
14Q LOSS MUTATED | 175 | 49 |
14Q LOSS WILD-TYPE | 370 | 40 |
P value = 0.000225 (Wilcoxon-test), Q value = 0.0018
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
14Q LOSS MUTATED | 34 | 71.5 (37.0) |
14Q LOSS WILD-TYPE | 108 | 92.7 (12.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
14Q LOSS MUTATED | 2 | 216 | 47 |
14Q LOSS WILD-TYPE | 64 | 312 | 240 |
P value = 0.00516 (Wilcoxon-test), Q value = 0.026
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
14Q LOSS MUTATED | 14 | 1984.8 (14.5) |
14Q LOSS WILD-TYPE | 60 | 1971.2 (15.3) |
P value = 0.0227 (Fisher's exact test), Q value = 0.088
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
14Q LOSS MUTATED | 0 | 3 | 24 | 231 |
14Q LOSS WILD-TYPE | 2 | 12 | 97 | 488 |
P value = 2.86e-05 (logrank test), Q value = 0.00029
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
15Q LOSS MUTATED | 68 | 28 | 0.1 - 194.8 (22.3) |
15Q LOSS WILD-TYPE | 805 | 200 | 0.1 - 152.0 (36.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
15Q LOSS MUTATED | 20 | 4 | 23 | 18 |
15Q LOSS WILD-TYPE | 435 | 100 | 168 | 86 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
15Q LOSS MUTATED | 23 | 5 | 36 | 5 |
15Q LOSS WILD-TYPE | 456 | 122 | 222 | 10 |
P value = 0.00097 (Fisher's exact test), Q value = 0.0064
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
15Q LOSS MUTATED | 22 | 10 | 2 |
15Q LOSS WILD-TYPE | 300 | 34 | 5 |
P value = 0.0139 (Fisher's exact test), Q value = 0.058
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
15Q LOSS MUTATED | 34 | 13 |
15Q LOSS WILD-TYPE | 511 | 76 |
P value = 0.0791 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
15Q LOSS MUTATED | 13 | 81.5 (26.7) |
15Q LOSS WILD-TYPE | 129 | 88.2 (22.4) |
P value = 0.046 (Fisher's exact test), Q value = 0.15
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
15Q LOSS MUTATED | 2 | 36 | 31 |
15Q LOSS WILD-TYPE | 64 | 492 | 256 |
P value = 6.06e-07 (logrank test), Q value = 6.3e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
16P LOSS MUTATED | 17 | 11 | 0.1 - 80.2 (28.1) |
16P LOSS WILD-TYPE | 856 | 217 | 0.1 - 194.8 (35.5) |
P value = 0.00851 (Fisher's exact test), Q value = 0.038
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
16P LOSS MUTATED | 4 | 2 | 6 | 6 |
16P LOSS WILD-TYPE | 451 | 102 | 185 | 98 |
P value = 0.00042 (Fisher's exact test), Q value = 0.0032
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
16P LOSS MUTATED | 4 | 2 | 9 | 3 |
16P LOSS WILD-TYPE | 475 | 125 | 249 | 12 |
P value = 0.00127 (Fisher's exact test), Q value = 0.008
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
16P LOSS MUTATED | 6 | 4 | 2 |
16P LOSS WILD-TYPE | 316 | 40 | 5 |
P value = 0.0689 (Fisher's exact test), Q value = 0.2
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
16P LOSS MUTATED | 4 | 10 | 4 |
16P LOSS WILD-TYPE | 62 | 518 | 283 |
P value = 4.99e-07 (logrank test), Q value = 6.3e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
16Q LOSS MUTATED | 27 | 16 | 0.1 - 80.2 (30.2) |
16Q LOSS WILD-TYPE | 846 | 212 | 0.1 - 194.8 (35.1) |
P value = 0.00502 (Fisher's exact test), Q value = 0.025
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
16Q LOSS MUTATED | 7 | 4 | 9 | 8 |
16Q LOSS WILD-TYPE | 448 | 100 | 182 | 96 |
P value = 0.00027 (Fisher's exact test), Q value = 0.0021
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
16Q LOSS MUTATED | 8 | 4 | 12 | 4 |
16Q LOSS WILD-TYPE | 471 | 123 | 246 | 11 |
P value = 0.00042 (Fisher's exact test), Q value = 0.0032
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
16Q LOSS MUTATED | 9 | 6 | 2 |
16Q LOSS WILD-TYPE | 313 | 38 | 5 |
P value = 0.00319 (Wilcoxon-test), Q value = 0.017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
17P LOSS MUTATED | 108 | 56.3 (14.7) |
17P LOSS WILD-TYPE | 767 | 60.7 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
17P LOSS MUTATED | 32 | 30 | 25 | 19 |
17P LOSS WILD-TYPE | 423 | 74 | 166 | 85 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
17P LOSS MUTATED | 33 | 33 | 40 | 3 |
17P LOSS WILD-TYPE | 446 | 94 | 218 | 12 |
P value = 0.00128 (Fisher's exact test), Q value = 0.008
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
17P LOSS MUTATED | 54 | 4 | 5 |
17P LOSS WILD-TYPE | 268 | 40 | 2 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
17P LOSS MUTATED | 50 | 47 | 12 |
17P LOSS WILD-TYPE | 16 | 481 | 275 |
P value = 0.00754 (logrank test), Q value = 0.035
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
17Q LOSS MUTATED | 80 | 17 | 0.4 - 152.0 (60.7) |
17Q LOSS WILD-TYPE | 793 | 211 | 0.1 - 194.8 (31.3) |
P value = 0.000261 (Wilcoxon-test), Q value = 0.0021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
17Q LOSS MUTATED | 81 | 54.6 (14.8) |
17Q LOSS WILD-TYPE | 794 | 60.7 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
17Q LOSS MUTATED | 23 | 27 | 18 | 12 |
17Q LOSS WILD-TYPE | 432 | 77 | 173 | 92 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
17Q LOSS MUTATED | 24 | 28 | 26 | 3 |
17Q LOSS WILD-TYPE | 455 | 99 | 232 | 12 |
P value = 0.00699 (Wilcoxon-test), Q value = 0.032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
17Q LOSS MUTATED | 10 | 99.0 (3.2) |
17Q LOSS WILD-TYPE | 132 | 86.7 (23.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
17Q LOSS MUTATED | 50 | 30 | 1 |
17Q LOSS WILD-TYPE | 16 | 498 | 286 |
P value = 3.28e-07 (logrank test), Q value = 5e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
18P LOSS MUTATED | 139 | 57 | 0.4 - 123.6 (25.7) |
18P LOSS WILD-TYPE | 734 | 171 | 0.1 - 194.8 (37.0) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
18P LOSS MUTATED | 45 | 11 | 51 | 30 |
18P LOSS WILD-TYPE | 410 | 93 | 140 | 74 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
18P LOSS MUTATED | 48 | 16 | 72 | 6 |
18P LOSS WILD-TYPE | 431 | 111 | 186 | 9 |
P value = 0.00689 (Fisher's exact test), Q value = 0.032
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
18P LOSS MUTATED | 54 | 13 | 4 |
18P LOSS WILD-TYPE | 268 | 31 | 3 |
P value = 0.0256 (Fisher's exact test), Q value = 0.096
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
18P LOSS MUTATED | 91 | 24 |
18P LOSS WILD-TYPE | 454 | 65 |
P value = 0.073 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
18P LOSS MUTATED | 7 | 1983.1 (12.8) |
18P LOSS WILD-TYPE | 67 | 1972.7 (16.0) |
P value = 0.0867 (Fisher's exact test), Q value = 0.24
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
18P LOSS MUTATED | 0 | 5 | 13 | 121 |
18P LOSS WILD-TYPE | 2 | 10 | 108 | 598 |
P value = 5.88e-07 (logrank test), Q value = 6.3e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
18Q LOSS MUTATED | 146 | 59 | 0.4 - 123.6 (25.8) |
18Q LOSS WILD-TYPE | 727 | 169 | 0.1 - 194.8 (37.0) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
18Q LOSS MUTATED | 50 | 12 | 51 | 31 |
18Q LOSS WILD-TYPE | 405 | 92 | 140 | 73 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
18Q LOSS MUTATED | 54 | 18 | 70 | 7 |
18Q LOSS WILD-TYPE | 425 | 109 | 188 | 8 |
P value = 0.00155 (Fisher's exact test), Q value = 0.0093
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
18Q LOSS MUTATED | 58 | 16 | 4 |
18Q LOSS WILD-TYPE | 264 | 28 | 3 |
P value = 0.0388 (Fisher's exact test), Q value = 0.13
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
18Q LOSS MUTATED | 94 | 24 |
18Q LOSS WILD-TYPE | 451 | 65 |
P value = 0.0422 (Fisher's exact test), Q value = 0.14
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 121 | 719 |
18Q LOSS MUTATED | 0 | 6 | 14 | 126 |
18Q LOSS WILD-TYPE | 2 | 9 | 107 | 593 |
P value = 0.00074 (logrank test), Q value = 0.0051
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
19P LOSS MUTATED | 27 | 12 | 0.9 - 109.9 (19.3) |
19P LOSS WILD-TYPE | 846 | 216 | 0.1 - 194.8 (35.9) |
P value = 0.00482 (Fisher's exact test), Q value = 0.025
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
19P LOSS MUTATED | 7 | 1 | 12 | 5 |
19P LOSS WILD-TYPE | 448 | 103 | 179 | 99 |
P value = 0.00164 (Fisher's exact test), Q value = 0.0098
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
19P LOSS MUTATED | 9 | 2 | 13 | 3 |
19P LOSS WILD-TYPE | 470 | 125 | 245 | 12 |
P value = 0.0377 (Fisher's exact test), Q value = 0.13
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
19P LOSS MUTATED | 7 | 3 | 1 |
19P LOSS WILD-TYPE | 315 | 41 | 6 |
P value = 0.0135 (Fisher's exact test), Q value = 0.056
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
19P LOSS MUTATED | 1 | 10 | 16 |
19P LOSS WILD-TYPE | 65 | 518 | 271 |
P value = 0.00121 (logrank test), Q value = 0.0077
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
19Q LOSS MUTATED | 22 | 9 | 0.9 - 96.6 (17.6) |
19Q LOSS WILD-TYPE | 851 | 219 | 0.1 - 194.8 (35.9) |
P value = 7e-04 (Fisher's exact test), Q value = 0.0049
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
19Q LOSS MUTATED | 4 | 1 | 11 | 5 |
19Q LOSS WILD-TYPE | 451 | 103 | 180 | 99 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00038
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
19Q LOSS MUTATED | 5 | 1 | 13 | 3 |
19Q LOSS WILD-TYPE | 474 | 126 | 245 | 12 |
P value = 0.00011 (Fisher's exact test), Q value = 0.00095
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
19Q LOSS MUTATED | 3 | 4 | 2 |
19Q LOSS WILD-TYPE | 319 | 40 | 5 |
P value = 0.00021 (Fisher's exact test), Q value = 0.0017
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
19Q LOSS MUTATED | 3 | 4 | 15 |
19Q LOSS WILD-TYPE | 63 | 524 | 272 |
P value = 0.00667 (Fisher's exact test), Q value = 0.031
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
20P LOSS MUTATED | 4 | 7 | 1 |
20P LOSS WILD-TYPE | 62 | 521 | 286 |
P value = 0.008 (Fisher's exact test), Q value = 0.037
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
20Q LOSS MUTATED | 3 | 3 | 0 |
20Q LOSS WILD-TYPE | 63 | 525 | 287 |
P value = 0.0633 (Fisher's exact test), Q value = 0.19
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
20Q LOSS MUTATED | 1 | 0 |
20Q LOSS WILD-TYPE | 41 | 621 |
P value = 0.0566 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
21Q LOSS MUTATED | 132 | 57.9 (13.5) |
21Q LOSS WILD-TYPE | 743 | 60.5 (12.3) |
P value = 8e-04 (Fisher's exact test), Q value = 0.0054
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
21Q LOSS MUTATED | 48 | 20 | 39 | 22 |
21Q LOSS WILD-TYPE | 407 | 84 | 152 | 82 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
21Q LOSS MUTATED | 48 | 24 | 55 | 6 |
21Q LOSS WILD-TYPE | 431 | 103 | 203 | 9 |
P value = 0.00319 (Fisher's exact test), Q value = 0.017
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
21Q LOSS MUTATED | 50 | 13 | 4 |
21Q LOSS WILD-TYPE | 272 | 31 | 3 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
21Q LOSS MUTATED | 35 | 55 | 43 |
21Q LOSS WILD-TYPE | 31 | 473 | 244 |
P value = 0.0566 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
21Q LOSS MUTATED | 10 | 1982.2 (12.9) |
21Q LOSS WILD-TYPE | 64 | 1972.4 (16.1) |
P value = 0.000828 (logrank test), Q value = 0.0056
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 873 | 228 | 0.1 - 194.8 (34.5) |
22Q LOSS MUTATED | 106 | 38 | 0.9 - 152.0 (25.9) |
22Q LOSS WILD-TYPE | 767 | 190 | 0.1 - 194.8 (36.9) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
22Q LOSS MUTATED | 34 | 10 | 39 | 20 |
22Q LOSS WILD-TYPE | 421 | 94 | 152 | 84 |
P value = 0.00021 (Fisher's exact test), Q value = 0.0017
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
22Q LOSS MUTATED | 41 | 14 | 51 | 1 |
22Q LOSS WILD-TYPE | 438 | 113 | 207 | 14 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00021
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
22Q LOSS MUTATED | 33 | 16 | 3 |
22Q LOSS WILD-TYPE | 289 | 28 | 4 |
P value = 0.0271 (Fisher's exact test), Q value = 0.1
nPatients | 0 | 1 |
---|---|---|
ALL | 545 | 89 |
22Q LOSS MUTATED | 53 | 16 |
22Q LOSS WILD-TYPE | 492 | 73 |
P value = 0.028 (Fisher's exact test), Q value = 0.1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 589 |
22Q LOSS MUTATED | 46 | 61 |
22Q LOSS WILD-TYPE | 246 | 528 |
P value = 0.00515 (Wilcoxon-test), Q value = 0.026
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 142 | 87.6 (22.8) |
22Q LOSS MUTATED | 25 | 72.8 (35.9) |
22Q LOSS WILD-TYPE | 117 | 90.8 (17.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
22Q LOSS MUTATED | 8 | 39 | 60 |
22Q LOSS WILD-TYPE | 58 | 489 | 227 |
P value = 0.0283 (Fisher's exact test), Q value = 0.1
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 621 |
22Q LOSS MUTATED | 10 | 72 |
22Q LOSS WILD-TYPE | 32 | 549 |
P value = 0.000927 (Wilcoxon-test), Q value = 0.0061
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
XP LOSS MUTATED | 117 | 55.9 (14.2) |
XP LOSS WILD-TYPE | 758 | 60.8 (12.1) |
P value = 0.00051 (Fisher's exact test), Q value = 0.0037
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
XP LOSS MUTATED | 41 | 22 | 35 | 15 |
XP LOSS WILD-TYPE | 414 | 82 | 156 | 89 |
P value = 0.00015 (Fisher's exact test), Q value = 0.0013
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
XP LOSS MUTATED | 42 | 25 | 49 | 2 |
XP LOSS WILD-TYPE | 437 | 102 | 209 | 13 |
P value = 0.00611 (Fisher's exact test), Q value = 0.029
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
XP LOSS MUTATED | 40 | 13 | 2 |
XP LOSS WILD-TYPE | 282 | 31 | 5 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
XP LOSS MUTATED | 38 | 47 | 33 |
XP LOSS WILD-TYPE | 28 | 481 | 254 |
P value = 0.00135 (Wilcoxon-test), Q value = 0.0083
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 875 | 60.1 (12.5) |
XQ LOSS MUTATED | 115 | 56.0 (14.2) |
XQ LOSS WILD-TYPE | 760 | 60.8 (12.1) |
P value = 0.00076 (Fisher's exact test), Q value = 0.0052
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 455 | 104 | 191 | 104 |
XQ LOSS MUTATED | 41 | 21 | 35 | 15 |
XQ LOSS WILD-TYPE | 414 | 83 | 156 | 89 |
P value = 0.00033 (Fisher's exact test), Q value = 0.0026
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 479 | 127 | 258 | 15 |
XQ LOSS MUTATED | 42 | 23 | 48 | 3 |
XQ LOSS WILD-TYPE | 437 | 104 | 210 | 12 |
P value = 0.00566 (Fisher's exact test), Q value = 0.028
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 322 | 44 | 7 |
XQ LOSS MUTATED | 40 | 13 | 2 |
XQ LOSS WILD-TYPE | 282 | 31 | 5 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 287 |
XQ LOSS MUTATED | 38 | 46 | 32 |
XQ LOSS WILD-TYPE | 28 | 482 | 255 |
-
Copy number data file = broad_values_by_arm.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/KIPAN-TP/19782227/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/KIPAN-TP/19775252/KIPAN-TP.merged_data.txt
-
Number of patients = 881
-
Number of significantly arm-level cnvs = 82
-
Number of selected clinical features = 14
-
Exclude regions that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.